JPH0495020A - Enzyme inhibitor - Google Patents
Enzyme inhibitorInfo
- Publication number
- JPH0495020A JPH0495020A JP2213138A JP21313890A JPH0495020A JP H0495020 A JPH0495020 A JP H0495020A JP 2213138 A JP2213138 A JP 2213138A JP 21313890 A JP21313890 A JP 21313890A JP H0495020 A JPH0495020 A JP H0495020A
- Authority
- JP
- Japan
- Prior art keywords
- sodium
- extract
- solvent
- water
- enzyme inhibitor
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 229940125532 enzyme inhibitor Drugs 0.000 title claims abstract description 12
- 239000002532 enzyme inhibitor Substances 0.000 title claims abstract description 12
- 239000000284 extract Substances 0.000 claims abstract description 44
- 239000002904 solvent Substances 0.000 claims abstract description 37
- 241000196324 Embryophyta Species 0.000 claims abstract description 28
- 239000000203 mixture Substances 0.000 claims description 21
- 241000736199 Paeonia Species 0.000 claims description 17
- 235000006484 Paeonia officinalis Nutrition 0.000 claims description 17
- 239000004480 active ingredient Substances 0.000 claims description 7
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 abstract description 51
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 abstract description 30
- 235000019441 ethanol Nutrition 0.000 abstract description 23
- 241000194019 Streptococcus mutans Species 0.000 abstract description 12
- 208000002925 dental caries Diseases 0.000 abstract description 6
- 230000015572 biosynthetic process Effects 0.000 abstract description 5
- 244000061508 Eriobotrya japonica Species 0.000 abstract description 3
- 235000009008 Eriobotrya japonica Nutrition 0.000 abstract description 3
- 102000000340 Glucosyltransferases Human genes 0.000 abstract description 2
- 108010055629 Glucosyltransferases Proteins 0.000 abstract description 2
- 230000001580 bacterial effect Effects 0.000 abstract description 2
- 201000001245 periodontitis Diseases 0.000 abstract description 2
- 238000013329 compounding Methods 0.000 abstract 1
- -1 troches Substances 0.000 description 15
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 description 14
- 229920001503 Glucan Polymers 0.000 description 13
- 230000000694 effects Effects 0.000 description 12
- KRKNYBCHXYNGOX-UHFFFAOYSA-N citric acid Chemical compound OC(=O)CC(O)(C(O)=O)CC(O)=O KRKNYBCHXYNGOX-UHFFFAOYSA-N 0.000 description 11
- 239000000606 toothpaste Substances 0.000 description 10
- HEMHJVSKTPXQMS-UHFFFAOYSA-M Sodium hydroxide Chemical compound [OH-].[Na+] HEMHJVSKTPXQMS-UHFFFAOYSA-M 0.000 description 9
- 239000011928 denatured alcohol Substances 0.000 description 9
- 229940034610 toothpaste Drugs 0.000 description 9
- 238000009472 formulation Methods 0.000 description 8
- 239000003205 fragrance Substances 0.000 description 7
- 235000011187 glycerol Nutrition 0.000 description 7
- 239000008213 purified water Substances 0.000 description 7
- OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 description 6
- 238000012360 testing method Methods 0.000 description 6
- 208000002064 Dental Plaque Diseases 0.000 description 5
- 238000000034 method Methods 0.000 description 5
- 210000000214 mouth Anatomy 0.000 description 5
- 239000002324 mouth wash Substances 0.000 description 5
- 208000028169 periodontal disease Diseases 0.000 description 5
- CVHZOJJKTDOEJC-UHFFFAOYSA-N saccharin Chemical compound C1=CC=C2C(=O)NS(=O)(=O)C2=C1 CVHZOJJKTDOEJC-UHFFFAOYSA-N 0.000 description 5
- 239000000243 solution Substances 0.000 description 5
- VTYYLEPIZMXCLO-UHFFFAOYSA-L Calcium carbonate Chemical compound [Ca+2].[O-]C([O-])=O VTYYLEPIZMXCLO-UHFFFAOYSA-L 0.000 description 4
- FBPFZTCFMRRESA-FSIIMWSLSA-N D-Glucitol Natural products OC[C@H](O)[C@H](O)[C@@H](O)[C@H](O)CO FBPFZTCFMRRESA-FSIIMWSLSA-N 0.000 description 4
- RTZKZFJDLAIYFH-UHFFFAOYSA-N Diethyl ether Chemical compound CCOCC RTZKZFJDLAIYFH-UHFFFAOYSA-N 0.000 description 4
- 108090000790 Enzymes Proteins 0.000 description 4
- 102000004190 Enzymes Human genes 0.000 description 4
- NBIIXXVUZAFLBC-UHFFFAOYSA-N Phosphoric acid Chemical compound OP(O)(O)=O NBIIXXVUZAFLBC-UHFFFAOYSA-N 0.000 description 4
- 229920003171 Poly (ethylene oxide) Polymers 0.000 description 4
- VYPSYNLAJGMNEJ-UHFFFAOYSA-N Silicium dioxide Chemical compound O=[Si]=O VYPSYNLAJGMNEJ-UHFFFAOYSA-N 0.000 description 4
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 4
- 229930006000 Sucrose Natural products 0.000 description 4
- 150000001298 alcohols Chemical class 0.000 description 4
- POJWUDADGALRAB-UHFFFAOYSA-N allantoin Chemical compound NC(=O)NC1NC(=O)NC1=O POJWUDADGALRAB-UHFFFAOYSA-N 0.000 description 4
- 238000003556 assay Methods 0.000 description 4
- 125000000484 butyl group Chemical group [H]C([*])([H])C([H])([H])C([H])([H])C([H])([H])[H] 0.000 description 4
- 235000009508 confectionery Nutrition 0.000 description 4
- 229940088598 enzyme Drugs 0.000 description 4
- 238000000605 extraction Methods 0.000 description 4
- 230000005764 inhibitory process Effects 0.000 description 4
- PUZPDOWCWNUUKD-UHFFFAOYSA-M sodium fluoride Chemical compound [F-].[Na+] PUZPDOWCWNUUKD-UHFFFAOYSA-M 0.000 description 4
- 239000000600 sorbitol Substances 0.000 description 4
- 235000010356 sorbitol Nutrition 0.000 description 4
- 239000006228 supernatant Substances 0.000 description 4
- CSCPPACGZOOCGX-UHFFFAOYSA-N Acetone Chemical compound CC(C)=O CSCPPACGZOOCGX-UHFFFAOYSA-N 0.000 description 3
- UHOVQNZJYSORNB-UHFFFAOYSA-N Benzene Chemical compound C1=CC=CC=C1 UHOVQNZJYSORNB-UHFFFAOYSA-N 0.000 description 3
- XEKOWRVHYACXOJ-UHFFFAOYSA-N Ethyl acetate Chemical compound CCOC(C)=O XEKOWRVHYACXOJ-UHFFFAOYSA-N 0.000 description 3
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 description 3
- DGAQECJNVWCQMB-PUAWFVPOSA-M Ilexoside XXIX Chemical compound C[C@@H]1CC[C@@]2(CC[C@@]3(C(=CC[C@H]4[C@]3(CC[C@@H]5[C@@]4(CC[C@@H](C5(C)C)OS(=O)(=O)[O-])C)C)[C@@H]2[C@]1(C)O)C)C(=O)O[C@H]6[C@@H]([C@H]([C@@H]([C@H](O6)CO)O)O)O.[Na+] DGAQECJNVWCQMB-PUAWFVPOSA-M 0.000 description 3
- KFZMGEQAYNKOFK-UHFFFAOYSA-N Isopropanol Chemical compound CC(C)O KFZMGEQAYNKOFK-UHFFFAOYSA-N 0.000 description 3
- DNIAPMSPPWPWGF-UHFFFAOYSA-N Propylene glycol Chemical compound CC(O)CO DNIAPMSPPWPWGF-UHFFFAOYSA-N 0.000 description 3
- DBMJMQXJHONAFJ-UHFFFAOYSA-M Sodium laurylsulphate Chemical compound [Na+].CCCCCCCCCCCCOS([O-])(=O)=O DBMJMQXJHONAFJ-UHFFFAOYSA-M 0.000 description 3
- CZMRCDWAGMRECN-UGDNZRGBSA-N Sucrose Chemical compound O[C@H]1[C@H](O)[C@@H](CO)O[C@@]1(CO)O[C@@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O1 CZMRCDWAGMRECN-UGDNZRGBSA-N 0.000 description 3
- GWEVSGVZZGPLCZ-UHFFFAOYSA-N Titan oxide Chemical compound O=[Ti]=O GWEVSGVZZGPLCZ-UHFFFAOYSA-N 0.000 description 3
- 239000001768 carboxy methyl cellulose Substances 0.000 description 3
- 229940112822 chewing gum Drugs 0.000 description 3
- 235000015218 chewing gum Nutrition 0.000 description 3
- 229960004106 citric acid Drugs 0.000 description 3
- 235000014113 dietary fatty acids Nutrition 0.000 description 3
- 239000000194 fatty acid Substances 0.000 description 3
- 229930195729 fatty acid Natural products 0.000 description 3
- 239000008103 glucose Substances 0.000 description 3
- VLKZOEOYAKHREP-UHFFFAOYSA-N n-Hexane Chemical compound CCCCCC VLKZOEOYAKHREP-UHFFFAOYSA-N 0.000 description 3
- 239000008363 phosphate buffer Substances 0.000 description 3
- 235000019333 sodium laurylsulphate Nutrition 0.000 description 3
- 239000005720 sucrose Substances 0.000 description 3
- GVJHHUAWPYXKBD-UHFFFAOYSA-N (±)-α-Tocopherol Chemical compound OC1=C(C)C(C)=C2OC(CCCC(C)CCCC(C)CCCC(C)C)(C)CCC2=C1C GVJHHUAWPYXKBD-UHFFFAOYSA-N 0.000 description 2
- VBICKXHEKHSIBG-UHFFFAOYSA-N 1-monostearoylglycerol Chemical compound CCCCCCCCCCCCCCCCCC(=O)OCC(O)CO VBICKXHEKHSIBG-UHFFFAOYSA-N 0.000 description 2
- WRMNZCZEMHIOCP-UHFFFAOYSA-N 2-phenylethanol Chemical compound OCCC1=CC=CC=C1 WRMNZCZEMHIOCP-UHFFFAOYSA-N 0.000 description 2
- POJWUDADGALRAB-PVQJCKRUSA-N Allantoin Natural products NC(=O)N[C@@H]1NC(=O)NC1=O POJWUDADGALRAB-PVQJCKRUSA-N 0.000 description 2
- CIWBSHSKHKDKBQ-JLAZNSOCSA-N Ascorbic acid Chemical compound OC[C@H](O)[C@H]1OC(=O)C(O)=C1O CIWBSHSKHKDKBQ-JLAZNSOCSA-N 0.000 description 2
- 206010006326 Breath odour Diseases 0.000 description 2
- ONJPCDHZCFGTSI-NJYHNNHUSA-N CC(C)CCCCCCCCCCCCCCC(=O)OC[C@@H](OC(=O)CCCCCCCCCCCCCCC(C)C)[C@H]1OC[C@H](O)[C@H]1O Chemical compound CC(C)CCCCCCCCCCCCCCC(=O)OC[C@@H](OC(=O)CCCCCCCCCCCCCCC(C)C)[C@H]1OC[C@H](O)[C@H]1O ONJPCDHZCFGTSI-NJYHNNHUSA-N 0.000 description 2
- 229920002307 Dextran Polymers 0.000 description 2
- GLZPCOQZEFWAFX-UHFFFAOYSA-N Geraniol Chemical compound CC(C)=CCCC(C)=CCO GLZPCOQZEFWAFX-UHFFFAOYSA-N 0.000 description 2
- FWKQNCXZGNBPFD-UHFFFAOYSA-N Guaiazulene Chemical compound CC(C)C1=CC=C(C)C2=CC=C(C)C2=C1 FWKQNCXZGNBPFD-UHFFFAOYSA-N 0.000 description 2
- VEXZGXHMUGYJMC-UHFFFAOYSA-N Hydrochloric acid Chemical compound Cl VEXZGXHMUGYJMC-UHFFFAOYSA-N 0.000 description 2
- 240000005308 Juniperus chinensis Species 0.000 description 2
- CSNNHWWHGAXBCP-UHFFFAOYSA-L Magnesium sulfate Chemical compound [Mg+2].[O-][S+2]([O-])([O-])[O-] CSNNHWWHGAXBCP-UHFFFAOYSA-L 0.000 description 2
- LRHPLDYGYMQRHN-UHFFFAOYSA-N N-Butanol Chemical compound CCCCO LRHPLDYGYMQRHN-UHFFFAOYSA-N 0.000 description 2
- 235000004347 Perilla Nutrition 0.000 description 2
- 244000124853 Perilla frutescens Species 0.000 description 2
- ISWSIDIOOBJBQZ-UHFFFAOYSA-N Phenol Chemical compound OC1=CC=CC=C1 ISWSIDIOOBJBQZ-UHFFFAOYSA-N 0.000 description 2
- 244000299790 Rheum rhabarbarum Species 0.000 description 2
- 235000009411 Rheum rhabarbarum Nutrition 0.000 description 2
- 239000004115 Sodium Silicate Substances 0.000 description 2
- 229920002472 Starch Polymers 0.000 description 2
- 244000250129 Trigonella foenum graecum Species 0.000 description 2
- 235000001484 Trigonella foenum graecum Nutrition 0.000 description 2
- DPXJVFZANSGRMM-UHFFFAOYSA-N acetic acid;2,3,4,5,6-pentahydroxyhexanal;sodium Chemical compound [Na].CC(O)=O.OCC(O)C(O)C(O)C(O)C=O DPXJVFZANSGRMM-UHFFFAOYSA-N 0.000 description 2
- 239000000443 aerosol Substances 0.000 description 2
- 229960000458 allantoin Drugs 0.000 description 2
- WNROFYMDJYEPJX-UHFFFAOYSA-K aluminium hydroxide Chemical compound [OH-].[OH-].[OH-].[Al+3] WNROFYMDJYEPJX-UHFFFAOYSA-K 0.000 description 2
- 229910000147 aluminium phosphate Inorganic materials 0.000 description 2
- 230000000202 analgesic effect Effects 0.000 description 2
- 230000002921 anti-spasmodic effect Effects 0.000 description 2
- 239000006286 aqueous extract Substances 0.000 description 2
- CUFNKYGDVFVPHO-UHFFFAOYSA-N azulene Chemical compound C1=CC=CC2=CC=CC2=C1 CUFNKYGDVFVPHO-UHFFFAOYSA-N 0.000 description 2
- WPYMKLBDIGXBTP-UHFFFAOYSA-N benzoic acid Chemical compound OC(=O)C1=CC=CC=C1 WPYMKLBDIGXBTP-UHFFFAOYSA-N 0.000 description 2
- QUKGYYKBILRGFE-UHFFFAOYSA-N benzyl acetate Chemical compound CC(=O)OCC1=CC=CC=C1 QUKGYYKBILRGFE-UHFFFAOYSA-N 0.000 description 2
- FUWUEFKEXZQKKA-UHFFFAOYSA-N beta-thujaplicin Chemical compound CC(C)C=1C=CC=C(O)C(=O)C=1 FUWUEFKEXZQKKA-UHFFFAOYSA-N 0.000 description 2
- 229910000019 calcium carbonate Inorganic materials 0.000 description 2
- FUFJGUQYACFECW-UHFFFAOYSA-L calcium hydrogenphosphate Chemical compound [Ca+2].OP([O-])([O-])=O FUFJGUQYACFECW-UHFFFAOYSA-L 0.000 description 2
- 239000004359 castor oil Substances 0.000 description 2
- 235000019438 castor oil Nutrition 0.000 description 2
- 238000005119 centrifugation Methods 0.000 description 2
- 239000003795 chemical substances by application Substances 0.000 description 2
- 230000001989 choleretic effect Effects 0.000 description 2
- 239000000812 cholinergic antagonist Substances 0.000 description 2
- 239000008367 deionised water Substances 0.000 description 2
- 229910021641 deionized water Inorganic materials 0.000 description 2
- 235000019700 dicalcium phosphate Nutrition 0.000 description 2
- FLKPEMZONWLCSK-UHFFFAOYSA-N diethyl phthalate Chemical compound CCOC(=O)C1=CC=CC=C1C(=O)OCC FLKPEMZONWLCSK-UHFFFAOYSA-N 0.000 description 2
- BNIILDVGGAEEIG-UHFFFAOYSA-L disodium hydrogen phosphate Chemical compound [Na+].[Na+].OP([O-])([O-])=O BNIILDVGGAEEIG-UHFFFAOYSA-L 0.000 description 2
- 229940079593 drug Drugs 0.000 description 2
- 239000003814 drug Substances 0.000 description 2
- 239000000469 ethanolic extract Substances 0.000 description 2
- RRAFCDWBNXTKKO-UHFFFAOYSA-N eugenol Chemical compound COC1=CC(CC=C)=CC=C1O RRAFCDWBNXTKKO-UHFFFAOYSA-N 0.000 description 2
- 150000004665 fatty acids Chemical class 0.000 description 2
- 229960005150 glycerol Drugs 0.000 description 2
- ZEMPKEQAKRGZGQ-XOQCFJPHSA-N glycerol triricinoleate Natural products CCCCCC[C@@H](O)CC=CCCCCCCCC(=O)OC[C@@H](COC(=O)CCCCCCCC=CC[C@@H](O)CCCCCC)OC(=O)CCCCCCCC=CC[C@H](O)CCCCCC ZEMPKEQAKRGZGQ-XOQCFJPHSA-N 0.000 description 2
- 241000411851 herbal medicine Species 0.000 description 2
- 239000004615 ingredient Substances 0.000 description 2
- 230000002401 inhibitory effect Effects 0.000 description 2
- CDOSHBSSFJOMGT-UHFFFAOYSA-N linalool Chemical compound CC(C)=CCCC(C)(O)C=C CDOSHBSSFJOMGT-UHFFFAOYSA-N 0.000 description 2
- 239000000865 liniment Substances 0.000 description 2
- OSWPMRLSEDHDFF-UHFFFAOYSA-N methyl salicylate Chemical compound COC(=O)C1=CC=CC=C1O OSWPMRLSEDHDFF-UHFFFAOYSA-N 0.000 description 2
- 244000005700 microbiome Species 0.000 description 2
- 239000012046 mixed solvent Substances 0.000 description 2
- 229940051866 mouthwash Drugs 0.000 description 2
- 230000007505 plaque formation Effects 0.000 description 2
- 229920001451 polypropylene glycol Polymers 0.000 description 2
- 239000000843 powder Substances 0.000 description 2
- 239000002244 precipitate Substances 0.000 description 2
- 239000000047 product Substances 0.000 description 2
- BDERNNFJNOPAEC-UHFFFAOYSA-N propan-1-ol Chemical compound CCCO BDERNNFJNOPAEC-UHFFFAOYSA-N 0.000 description 2
- 235000019204 saccharin Nutrition 0.000 description 2
- 229940081974 saccharin Drugs 0.000 description 2
- 239000000901 saccharin and its Na,K and Ca salt Substances 0.000 description 2
- 239000011734 sodium Substances 0.000 description 2
- 229910052708 sodium Inorganic materials 0.000 description 2
- WXMKPNITSTVMEF-UHFFFAOYSA-M sodium benzoate Chemical compound [Na+].[O-]C(=O)C1=CC=CC=C1 WXMKPNITSTVMEF-UHFFFAOYSA-M 0.000 description 2
- 235000010234 sodium benzoate Nutrition 0.000 description 2
- 239000004299 sodium benzoate Substances 0.000 description 2
- 235000019812 sodium carboxymethyl cellulose Nutrition 0.000 description 2
- 229920001027 sodium carboxymethylcellulose Polymers 0.000 description 2
- 239000011780 sodium chloride Substances 0.000 description 2
- 239000011775 sodium fluoride Substances 0.000 description 2
- 235000013024 sodium fluoride Nutrition 0.000 description 2
- 229960000414 sodium fluoride Drugs 0.000 description 2
- 229910052911 sodium silicate Inorganic materials 0.000 description 2
- 241000894007 species Species 0.000 description 2
- 239000008107 starch Substances 0.000 description 2
- 235000019698 starch Nutrition 0.000 description 2
- 238000003756 stirring Methods 0.000 description 2
- 235000000346 sugar Nutrition 0.000 description 2
- 239000006188 syrup Substances 0.000 description 2
- 235000020357 syrup Nutrition 0.000 description 2
- 239000003826 tablet Substances 0.000 description 2
- MGSRCZKZVOBKFT-UHFFFAOYSA-N thymol Chemical compound CC(C)C1=CC=C(C)C=C1O MGSRCZKZVOBKFT-UHFFFAOYSA-N 0.000 description 2
- 235000001019 trigonella foenum-graecum Nutrition 0.000 description 2
- JIAARYAFYJHUJI-UHFFFAOYSA-L zinc dichloride Chemical compound [Cl-].[Cl-].[Zn+2] JIAARYAFYJHUJI-UHFFFAOYSA-L 0.000 description 2
- DTGKSKDOIYIVQL-NQMVMOMDSA-N (+)-Borneol Natural products C1C[C@]2(C)[C@H](O)C[C@@H]1C2(C)C DTGKSKDOIYIVQL-NQMVMOMDSA-N 0.000 description 1
- DTGKSKDOIYIVQL-WEDXCCLWSA-N (+)-borneol Chemical compound C1C[C@@]2(C)[C@@H](O)C[C@@H]1C2(C)C DTGKSKDOIYIVQL-WEDXCCLWSA-N 0.000 description 1
- NOOLISFMXDJSKH-KXUCPTDWSA-N (-)-Menthol Chemical compound CC(C)[C@@H]1CC[C@@H](C)C[C@H]1O NOOLISFMXDJSKH-KXUCPTDWSA-N 0.000 description 1
- FTLYMKDSHNWQKD-UHFFFAOYSA-N (2,4,5-trichlorophenyl)boronic acid Chemical compound OB(O)C1=CC(Cl)=C(Cl)C=C1Cl FTLYMKDSHNWQKD-UHFFFAOYSA-N 0.000 description 1
- 239000001490 (3R)-3,7-dimethylocta-1,6-dien-3-ol Substances 0.000 description 1
- KJPRLNWUNMBNBZ-QPJJXVBHSA-N (E)-cinnamaldehyde Chemical compound O=C\C=C\C1=CC=CC=C1 KJPRLNWUNMBNBZ-QPJJXVBHSA-N 0.000 description 1
- OOCCDEMITAIZTP-QPJJXVBHSA-N (E)-cinnamyl alcohol Chemical compound OC\C=C\C1=CC=CC=C1 OOCCDEMITAIZTP-QPJJXVBHSA-N 0.000 description 1
- CDOSHBSSFJOMGT-JTQLQIEISA-N (R)-linalool Natural products CC(C)=CCC[C@@](C)(O)C=C CDOSHBSSFJOMGT-JTQLQIEISA-N 0.000 description 1
- ZORQXIQZAOLNGE-UHFFFAOYSA-N 1,1-difluorocyclohexane Chemical compound FC1(F)CCCCC1 ZORQXIQZAOLNGE-UHFFFAOYSA-N 0.000 description 1
- IXPNQXFRVYWDDI-UHFFFAOYSA-N 1-methyl-2,4-dioxo-1,3-diazinane-5-carboximidamide Chemical compound CN1CC(C(N)=N)C(=O)NC1=O IXPNQXFRVYWDDI-UHFFFAOYSA-N 0.000 description 1
- CHHHXKFHOYLYRE-UHFFFAOYSA-M 2,4-Hexadienoic acid, potassium salt (1:1), (2E,4E)- Chemical compound [K+].CC=CC=CC([O-])=O CHHHXKFHOYLYRE-UHFFFAOYSA-M 0.000 description 1
- TWJNQYPJQDRXPH-UHFFFAOYSA-N 2-cyanobenzohydrazide Chemical compound NNC(=O)C1=CC=CC=C1C#N TWJNQYPJQDRXPH-UHFFFAOYSA-N 0.000 description 1
- YIJFIIXHVSHQEN-UHFFFAOYSA-N 3-Aminocaproic acid Chemical compound CCCC(N)CC(O)=O YIJFIIXHVSHQEN-UHFFFAOYSA-N 0.000 description 1
- XGRSAFKZAGGXJV-UHFFFAOYSA-N 3-azaniumyl-3-cyclohexylpropanoate Chemical compound OC(=O)CC(N)C1CCCCC1 XGRSAFKZAGGXJV-UHFFFAOYSA-N 0.000 description 1
- CYDQOEWLBCCFJZ-UHFFFAOYSA-N 4-(4-fluorophenyl)oxane-4-carboxylic acid Chemical compound C=1C=C(F)C=CC=1C1(C(=O)O)CCOCC1 CYDQOEWLBCCFJZ-UHFFFAOYSA-N 0.000 description 1
- XZIIFPSPUDAGJM-UHFFFAOYSA-N 6-chloro-2-n,2-n-diethylpyrimidine-2,4-diamine Chemical compound CCN(CC)C1=NC(N)=CC(Cl)=N1 XZIIFPSPUDAGJM-UHFFFAOYSA-N 0.000 description 1
- 241000332371 Abutilon x hybridum Species 0.000 description 1
- 241001199641 Acacia silvestris Species 0.000 description 1
- 208000032484 Accidental exposure to product Diseases 0.000 description 1
- 240000004731 Acer pseudoplatanus Species 0.000 description 1
- 235000002754 Acer pseudoplatanus Nutrition 0.000 description 1
- QTBSBXVTEAMEQO-UHFFFAOYSA-M Acetate Chemical compound CC([O-])=O QTBSBXVTEAMEQO-UHFFFAOYSA-M 0.000 description 1
- 229920001817 Agar Polymers 0.000 description 1
- GUBGYTABKSRVRQ-XLOQQCSPSA-N Alpha-Lactose Chemical compound O[C@@H]1[C@@H](O)[C@@H](O)[C@@H](CO)O[C@H]1O[C@@H]1[C@@H](CO)O[C@H](O)[C@H](O)[C@H]1O GUBGYTABKSRVRQ-XLOQQCSPSA-N 0.000 description 1
- 239000005995 Aluminium silicate Substances 0.000 description 1
- 235000015701 Artemisia arbuscula Nutrition 0.000 description 1
- 235000002657 Artemisia tridentata Nutrition 0.000 description 1
- 235000003261 Artemisia vulgaris Nutrition 0.000 description 1
- 240000006891 Artemisia vulgaris Species 0.000 description 1
- 108700033546 Aspergillus terreus M3328 Mutastein Proteins 0.000 description 1
- 241000894006 Bacteria Species 0.000 description 1
- 239000005711 Benzoic acid Substances 0.000 description 1
- 229920002134 Carboxymethyl cellulose Polymers 0.000 description 1
- NPBVQXIMTZKSBA-UHFFFAOYSA-N Chavibetol Natural products COC1=CC=C(CC=C)C=C1O NPBVQXIMTZKSBA-UHFFFAOYSA-N 0.000 description 1
- WJLVQTJZDCGNJN-UHFFFAOYSA-N Chlorhexidine hydrochloride Chemical compound Cl.Cl.C=1C=C(Cl)C=CC=1NC(N)=NC(N)=NCCCCCCN=C(N)N=C(N)NC1=CC=C(Cl)C=C1 WJLVQTJZDCGNJN-UHFFFAOYSA-N 0.000 description 1
- VEXZGXHMUGYJMC-UHFFFAOYSA-M Chloride anion Chemical compound [Cl-] VEXZGXHMUGYJMC-UHFFFAOYSA-M 0.000 description 1
- 229910021593 Copper(I) fluoride Inorganic materials 0.000 description 1
- 235000009917 Crataegus X brevipes Nutrition 0.000 description 1
- 235000013204 Crataegus X haemacarpa Nutrition 0.000 description 1
- 235000009685 Crataegus X maligna Nutrition 0.000 description 1
- 235000009444 Crataegus X rubrocarnea Nutrition 0.000 description 1
- 235000009486 Crataegus bullatus Nutrition 0.000 description 1
- 235000017181 Crataegus chrysocarpa Nutrition 0.000 description 1
- 235000009682 Crataegus limnophila Nutrition 0.000 description 1
- 240000000171 Crataegus monogyna Species 0.000 description 1
- 235000004423 Crataegus monogyna Nutrition 0.000 description 1
- 235000002313 Crataegus paludosa Nutrition 0.000 description 1
- 235000009840 Crataegus x incaedua Nutrition 0.000 description 1
- FBPFZTCFMRRESA-JGWLITMVSA-N D-glucitol Chemical compound OC[C@H](O)[C@@H](O)[C@H](O)[C@H](O)CO FBPFZTCFMRRESA-JGWLITMVSA-N 0.000 description 1
- 108010001682 Dextranase Proteins 0.000 description 1
- FEWJPZIEWOKRBE-JCYAYHJZSA-N Dextrotartaric acid Chemical compound OC(=O)[C@H](O)[C@@H](O)C(O)=O FEWJPZIEWOKRBE-JCYAYHJZSA-N 0.000 description 1
- ZGTMUACCHSMWAC-UHFFFAOYSA-L EDTA disodium salt (anhydrous) Chemical compound [Na+].[Na+].OC(=O)CN(CC([O-])=O)CCN(CC(O)=O)CC([O-])=O ZGTMUACCHSMWAC-UHFFFAOYSA-L 0.000 description 1
- 101000925662 Enterobacteria phage PRD1 Endolysin Proteins 0.000 description 1
- 239000005770 Eugenol Substances 0.000 description 1
- 102000009123 Fibrin Human genes 0.000 description 1
- 108010073385 Fibrin Proteins 0.000 description 1
- BWGVNKXGVNDBDI-UHFFFAOYSA-N Fibrin monomer Chemical compound CNC(=O)CNC(=O)CN BWGVNKXGVNDBDI-UHFFFAOYSA-N 0.000 description 1
- 108010010803 Gelatin Proteins 0.000 description 1
- 239000005792 Geraniol Substances 0.000 description 1
- GLZPCOQZEFWAFX-YFHOEESVSA-N Geraniol Natural products CC(C)=CCC\C(C)=C/CO GLZPCOQZEFWAFX-YFHOEESVSA-N 0.000 description 1
- AEMRFAOFKBGASW-UHFFFAOYSA-M Glycolate Chemical compound OCC([O-])=O AEMRFAOFKBGASW-UHFFFAOYSA-M 0.000 description 1
- 102000003886 Glycoproteins Human genes 0.000 description 1
- 108090000288 Glycoproteins Proteins 0.000 description 1
- UFHFLCQGNIYNRP-UHFFFAOYSA-N Hydrogen Chemical compound [H][H] UFHFLCQGNIYNRP-UHFFFAOYSA-N 0.000 description 1
- 239000004354 Hydroxyethyl cellulose Substances 0.000 description 1
- 229920000663 Hydroxyethyl cellulose Polymers 0.000 description 1
- 206010061218 Inflammation Diseases 0.000 description 1
- GUBGYTABKSRVRQ-QKKXKWKRSA-N Lactose Natural products OC[C@H]1O[C@@H](O[C@H]2[C@H](O)[C@@H](O)C(O)O[C@@H]2CO)[C@H](O)[C@@H](O)[C@H]1O GUBGYTABKSRVRQ-QKKXKWKRSA-N 0.000 description 1
- 241000134253 Lanka Species 0.000 description 1
- 240000007472 Leucaena leucocephala Species 0.000 description 1
- 235000010643 Leucaena leucocephala Nutrition 0.000 description 1
- VTAJIXDZFCRWBR-UHFFFAOYSA-N Licoricesaponin B2 Natural products C1C(C2C(C3(CCC4(C)CCC(C)(CC4C3=CC2)C(O)=O)C)(C)CC2)(C)C2C(C)(C)CC1OC1OC(C(O)=O)C(O)C(O)C1OC1OC(C(O)=O)C(O)C(O)C1O VTAJIXDZFCRWBR-UHFFFAOYSA-N 0.000 description 1
- 241000604893 Lindera umbellata Species 0.000 description 1
- 244000246386 Mentha pulegium Species 0.000 description 1
- 235000016257 Mentha pulegium Nutrition 0.000 description 1
- 235000004357 Mentha x piperita Nutrition 0.000 description 1
- 108010014251 Muramidase Proteins 0.000 description 1
- 102000016943 Muramidase Human genes 0.000 description 1
- 235000021360 Myristic acid Nutrition 0.000 description 1
- TUNFSRHWOTWDNC-UHFFFAOYSA-N Myristic acid Natural products CCCCCCCCCCCCCC(O)=O TUNFSRHWOTWDNC-UHFFFAOYSA-N 0.000 description 1
- 108010062010 N-Acetylmuramoyl-L-alanine Amidase Proteins 0.000 description 1
- AMQJEAYHLZJPGS-UHFFFAOYSA-N N-Pentanol Chemical compound CCCCCO AMQJEAYHLZJPGS-UHFFFAOYSA-N 0.000 description 1
- GXCLVBGFBYZDAG-UHFFFAOYSA-N N-[2-(1H-indol-3-yl)ethyl]-N-methylprop-2-en-1-amine Chemical compound CN(CCC1=CNC2=C1C=CC=C2)CC=C GXCLVBGFBYZDAG-UHFFFAOYSA-N 0.000 description 1
- 229910019142 PO4 Inorganic materials 0.000 description 1
- 240000004371 Panax ginseng Species 0.000 description 1
- 235000005035 Panax pseudoginseng ssp. pseudoginseng Nutrition 0.000 description 1
- 235000003140 Panax quinquefolius Nutrition 0.000 description 1
- 239000001888 Peptone Substances 0.000 description 1
- 108010080698 Peptones Proteins 0.000 description 1
- 241000199919 Phaeophyceae Species 0.000 description 1
- 235000006485 Platanus occidentalis Nutrition 0.000 description 1
- 239000002202 Polyethylene glycol Substances 0.000 description 1
- 229920001213 Polysorbate 20 Polymers 0.000 description 1
- 229920001214 Polysorbate 60 Polymers 0.000 description 1
- UVMRYBDEERADNV-UHFFFAOYSA-N Pseudoeugenol Natural products COC1=CC(C(C)=C)=CC=C1O UVMRYBDEERADNV-UHFFFAOYSA-N 0.000 description 1
- 244000184734 Pyrus japonica Species 0.000 description 1
- 241000219492 Quercus Species 0.000 description 1
- WINXNKPZLFISPD-UHFFFAOYSA-M Saccharin sodium Chemical compound [Na+].C1=CC=C2C(=O)[N-]S(=O)(=O)C2=C1 WINXNKPZLFISPD-UHFFFAOYSA-M 0.000 description 1
- UIIMBOGNXHQVGW-DEQYMQKBSA-M Sodium bicarbonate-14C Chemical compound [Na+].O[14C]([O-])=O UIIMBOGNXHQVGW-DEQYMQKBSA-M 0.000 description 1
- 239000004288 Sodium dehydroacetate Substances 0.000 description 1
- 229920002125 Sokalan® Polymers 0.000 description 1
- 244000228451 Stevia rebaudiana Species 0.000 description 1
- 241000187747 Streptomyces Species 0.000 description 1
- 244000223014 Syzygium aromaticum Species 0.000 description 1
- 235000016639 Syzygium aromaticum Nutrition 0.000 description 1
- FEWJPZIEWOKRBE-UHFFFAOYSA-N Tartaric acid Natural products [H+].[H+].[O-]C(=O)C(O)C(O)C([O-])=O FEWJPZIEWOKRBE-UHFFFAOYSA-N 0.000 description 1
- 239000005844 Thymol Substances 0.000 description 1
- RTAQQCXQSZGOHL-UHFFFAOYSA-N Titanium Chemical compound [Ti] RTAQQCXQSZGOHL-UHFFFAOYSA-N 0.000 description 1
- AXMVYSVVTMKQSL-UHFFFAOYSA-N UNPD142122 Natural products OC1=CC=C(C=CC=O)C=C1O AXMVYSVVTMKQSL-UHFFFAOYSA-N 0.000 description 1
- 208000024780 Urticaria Diseases 0.000 description 1
- BZHJMEDXRYGGRV-UHFFFAOYSA-N Vinyl chloride Chemical compound ClC=C BZHJMEDXRYGGRV-UHFFFAOYSA-N 0.000 description 1
- 229930003427 Vitamin E Natural products 0.000 description 1
- 239000003082 abrasive agent Substances 0.000 description 1
- 238000002835 absorbance Methods 0.000 description 1
- 229940022663 acetate Drugs 0.000 description 1
- 239000000853 adhesive Substances 0.000 description 1
- 230000001070 adhesive effect Effects 0.000 description 1
- 230000002411 adverse Effects 0.000 description 1
- 239000008272 agar Substances 0.000 description 1
- LFVVNPBBFUSSHL-UHFFFAOYSA-N alexidine Chemical compound CCCCC(CC)CNC(=N)NC(=N)NCCCCCCNC(=N)NC(=N)NCC(CC)CCCC LFVVNPBBFUSSHL-UHFFFAOYSA-N 0.000 description 1
- 229950010221 alexidine Drugs 0.000 description 1
- OOCCDEMITAIZTP-UHFFFAOYSA-N allylic benzylic alcohol Natural products OCC=CC1=CC=CC=C1 OOCCDEMITAIZTP-UHFFFAOYSA-N 0.000 description 1
- 229940069521 aloe extract Drugs 0.000 description 1
- TUFYVOCKVJOUIR-UHFFFAOYSA-N alpha-Thujaplicin Natural products CC(C)C=1C=CC=CC(=O)C=1O TUFYVOCKVJOUIR-UHFFFAOYSA-N 0.000 description 1
- 235000012211 aluminium silicate Nutrition 0.000 description 1
- 229940024545 aluminum hydroxide Drugs 0.000 description 1
- 229940009868 aluminum magnesium silicate Drugs 0.000 description 1
- 229940024548 aluminum oxide Drugs 0.000 description 1
- WMGSQTMJHBYJMQ-UHFFFAOYSA-N aluminum;magnesium;silicate Chemical compound [Mg+2].[Al+3].[O-][Si]([O-])([O-])[O-] WMGSQTMJHBYJMQ-UHFFFAOYSA-N 0.000 description 1
- BFNBIHQBYMNNAN-UHFFFAOYSA-N ammonium sulfate Chemical class N.N.OS(O)(=O)=O BFNBIHQBYMNNAN-UHFFFAOYSA-N 0.000 description 1
- 229910021417 amorphous silicon Inorganic materials 0.000 description 1
- 230000036592 analgesia Effects 0.000 description 1
- 229960004543 anhydrous citric acid Drugs 0.000 description 1
- 230000000954 anitussive effect Effects 0.000 description 1
- 230000000507 anthelmentic effect Effects 0.000 description 1
- 230000003110 anti-inflammatory effect Effects 0.000 description 1
- 229940124584 antitussives Drugs 0.000 description 1
- 239000007864 aqueous solution Substances 0.000 description 1
- 235000010323 ascorbic acid Nutrition 0.000 description 1
- 229960005070 ascorbic acid Drugs 0.000 description 1
- 239000011668 ascorbic acid Substances 0.000 description 1
- 235000019606 astringent taste Nutrition 0.000 description 1
- 239000002585 base Substances 0.000 description 1
- 235000013871 bee wax Nutrition 0.000 description 1
- 235000015278 beef Nutrition 0.000 description 1
- 239000012166 beeswax Substances 0.000 description 1
- 229940092738 beeswax Drugs 0.000 description 1
- 239000000440 bentonite Substances 0.000 description 1
- 229910000278 bentonite Inorganic materials 0.000 description 1
- SVPXDRXYRYOSEX-UHFFFAOYSA-N bentoquatam Chemical compound O.O=[Si]=O.O=[Al]O[Al]=O SVPXDRXYRYOSEX-UHFFFAOYSA-N 0.000 description 1
- 235000010233 benzoic acid Nutrition 0.000 description 1
- 229960004365 benzoic acid Drugs 0.000 description 1
- 229940007550 benzyl acetate Drugs 0.000 description 1
- 239000011230 binding agent Substances 0.000 description 1
- 230000036772 blood pressure Effects 0.000 description 1
- 238000009395 breeding Methods 0.000 description 1
- 230000001488 breeding effect Effects 0.000 description 1
- RRKTZKIUPZVBMF-IBTVXLQLSA-N brucine Chemical compound O([C@@H]1[C@H]([C@H]2C3)[C@@H]4N(C(C1)=O)C=1C=C(C(=CC=11)OC)OC)CC=C2CN2[C@@H]3[C@]41CC2 RRKTZKIUPZVBMF-IBTVXLQLSA-N 0.000 description 1
- RRKTZKIUPZVBMF-UHFFFAOYSA-N brucine Natural products C1=2C=C(OC)C(OC)=CC=2N(C(C2)=O)C3C(C4C5)C2OCC=C4CN2C5C31CC2 RRKTZKIUPZVBMF-UHFFFAOYSA-N 0.000 description 1
- JUNWLZAGQLJVLR-UHFFFAOYSA-J calcium diphosphate Chemical compound [Ca+2].[Ca+2].[O-]P([O-])(=O)OP([O-])([O-])=O JUNWLZAGQLJVLR-UHFFFAOYSA-J 0.000 description 1
- XAAHAAMILDNBPS-UHFFFAOYSA-L calcium hydrogenphosphate dihydrate Chemical compound O.O.[Ca+2].OP([O-])([O-])=O XAAHAAMILDNBPS-UHFFFAOYSA-L 0.000 description 1
- 229940043256 calcium pyrophosphate Drugs 0.000 description 1
- 150000001720 carbohydrates Chemical class 0.000 description 1
- 125000004432 carbon atom Chemical group C* 0.000 description 1
- 235000010948 carboxy methyl cellulose Nutrition 0.000 description 1
- 239000008112 carboxymethyl-cellulose Substances 0.000 description 1
- 235000010418 carrageenan Nutrition 0.000 description 1
- 239000000679 carrageenan Substances 0.000 description 1
- 229920001525 carrageenan Polymers 0.000 description 1
- 229940113118 carrageenan Drugs 0.000 description 1
- 210000004027 cell Anatomy 0.000 description 1
- 239000001913 cellulose Substances 0.000 description 1
- 229920002678 cellulose Polymers 0.000 description 1
- 229960001927 cetylpyridinium chloride Drugs 0.000 description 1
- YMKDRGPMQRFJGP-UHFFFAOYSA-M cetylpyridinium chloride Chemical compound [Cl-].CCCCCCCCCCCCCCCC[N+]1=CC=CC=C1 YMKDRGPMQRFJGP-UHFFFAOYSA-M 0.000 description 1
- 238000006243 chemical reaction Methods 0.000 description 1
- 229960003333 chlorhexidine gluconate Drugs 0.000 description 1
- YZIYKJHYYHPJIB-UUPCJSQJSA-N chlorhexidine gluconate Chemical compound OC[C@@H](O)[C@@H](O)[C@H](O)[C@@H](O)C(O)=O.OC[C@@H](O)[C@@H](O)[C@H](O)[C@@H](O)C(O)=O.C1=CC(Cl)=CC=C1NC(=N)NC(=N)NCCCCCCNC(=N)NC(=N)NC1=CC=C(Cl)C=C1 YZIYKJHYYHPJIB-UUPCJSQJSA-N 0.000 description 1
- 229960004504 chlorhexidine hydrochloride Drugs 0.000 description 1
- 239000000731 choleretic agent Substances 0.000 description 1
- 229940117916 cinnamic aldehyde Drugs 0.000 description 1
- KJPRLNWUNMBNBZ-UHFFFAOYSA-N cinnamic aldehyde Natural products O=CC=CC1=CC=CC=C1 KJPRLNWUNMBNBZ-UHFFFAOYSA-N 0.000 description 1
- 235000015165 citric acid Nutrition 0.000 description 1
- 235000019864 coconut oil Nutrition 0.000 description 1
- 239000003240 coconut oil Substances 0.000 description 1
- 238000007796 conventional method Methods 0.000 description 1
- HWDGVJUIHRPKFR-UHFFFAOYSA-I copper;trisodium;18-(2-carboxylatoethyl)-20-(carboxylatomethyl)-12-ethenyl-7-ethyl-3,8,13,17-tetramethyl-17,18-dihydroporphyrin-21,23-diide-2-carboxylate Chemical compound [Na+].[Na+].[Na+].[Cu+2].N1=C(C(CC([O-])=O)=C2C(C(C)C(C=C3C(=C(C=C)C(=C4)[N-]3)C)=N2)CCC([O-])=O)C(=C([O-])[O-])C(C)=C1C=C1C(CC)=C(C)C4=N1 HWDGVJUIHRPKFR-UHFFFAOYSA-I 0.000 description 1
- 239000006071 cream Substances 0.000 description 1
- POZRVZJJTULAOH-LHZXLZLDSA-N danazol Chemical compound C1[C@]2(C)[C@H]3CC[C@](C)([C@](CC4)(O)C#C)[C@@H]4[C@@H]3CCC2=CC2=C1C=NO2 POZRVZJJTULAOH-LHZXLZLDSA-N 0.000 description 1
- 238000000354 decomposition reaction Methods 0.000 description 1
- VWTINHYPRWEBQY-UHFFFAOYSA-N denatonium Chemical compound [O-]C(=O)C1=CC=CC=C1.C=1C=CC=CC=1C[N+](CC)(CC)CC(=O)NC1=C(C)C=CC=C1C VWTINHYPRWEBQY-UHFFFAOYSA-N 0.000 description 1
- 229960001610 denatonium benzoate Drugs 0.000 description 1
- 210000003298 dental enamel Anatomy 0.000 description 1
- 238000011161 development Methods 0.000 description 1
- RUYJNKYXOHIGPH-UHFFFAOYSA-N dialuminum;trioxido(trioxidosilyloxy)silane Chemical compound [Al+3].[Al+3].[O-][Si]([O-])([O-])O[Si]([O-])([O-])[O-] RUYJNKYXOHIGPH-UHFFFAOYSA-N 0.000 description 1
- 235000019821 dicalcium diphosphate Nutrition 0.000 description 1
- PCHPORCSPXIHLZ-UHFFFAOYSA-N diphenhydramine hydrochloride Chemical compound [Cl-].C=1C=CC=CC=1C(OCC[NH+](C)C)C1=CC=CC=C1 PCHPORCSPXIHLZ-UHFFFAOYSA-N 0.000 description 1
- ZPWVASYFFYYZEW-UHFFFAOYSA-L dipotassium hydrogen phosphate Chemical compound [K+].[K+].OP([O-])([O-])=O ZPWVASYFFYYZEW-UHFFFAOYSA-L 0.000 description 1
- 235000019797 dipotassium phosphate Nutrition 0.000 description 1
- 229910000396 dipotassium phosphate Inorganic materials 0.000 description 1
- 201000010099 disease Diseases 0.000 description 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 1
- 229910000397 disodium phosphate Inorganic materials 0.000 description 1
- 235000019800 disodium phosphate Nutrition 0.000 description 1
- WODOUQLMOIMKAL-FJSYBICCSA-L disodium;(2s)-2-(octadecanoylamino)pentanedioate Chemical compound [Na+].[Na+].CCCCCCCCCCCCCCCCCC(=O)N[C@H](C([O-])=O)CCC([O-])=O WODOUQLMOIMKAL-FJSYBICCSA-L 0.000 description 1
- 239000002934 diuretic Substances 0.000 description 1
- 230000001882 diuretic effect Effects 0.000 description 1
- MOTZDAYCYVMXPC-UHFFFAOYSA-N dodecyl hydrogen sulfate Chemical compound CCCCCCCCCCCCOS(O)(=O)=O MOTZDAYCYVMXPC-UHFFFAOYSA-N 0.000 description 1
- 229940043264 dodecyl sulfate Drugs 0.000 description 1
- 229940124274 edetate disodium Drugs 0.000 description 1
- 238000002481 ethanol extraction Methods 0.000 description 1
- BEFDCLMNVWHSGT-UHFFFAOYSA-N ethenylcyclopentane Chemical compound C=CC1CCCC1 BEFDCLMNVWHSGT-UHFFFAOYSA-N 0.000 description 1
- 125000001495 ethyl group Chemical group [H]C([H])([H])C([H])([H])* 0.000 description 1
- 239000010642 eucalyptus oil Substances 0.000 description 1
- 229940044949 eucalyptus oil Drugs 0.000 description 1
- 229960002217 eugenol Drugs 0.000 description 1
- 108010000165 exo-1,3-alpha-glucanase Proteins 0.000 description 1
- 239000003172 expectorant agent Substances 0.000 description 1
- 230000003419 expectorant effect Effects 0.000 description 1
- 229950003499 fibrin Drugs 0.000 description 1
- 239000004088 foaming agent Substances 0.000 description 1
- 235000003599 food sweetener Nutrition 0.000 description 1
- FODTZLFLDFKIQH-FSVGXZBPSA-N gamma-Oryzanol (TN) Chemical compound C1=C(O)C(OC)=CC(\C=C\C(=O)O[C@@H]2C([C@@H]3CC[C@H]4[C@]5(C)CC[C@@H]([C@@]5(C)CC[C@@]54C[C@@]53CC2)[C@H](C)CCC=C(C)C)(C)C)=C1 FODTZLFLDFKIQH-FSVGXZBPSA-N 0.000 description 1
- WIGCFUFOHFEKBI-UHFFFAOYSA-N gamma-tocopherol Natural products CC(C)CCCC(C)CCCC(C)CCCC1CCC2C(C)C(O)C(C)C(C)C2O1 WIGCFUFOHFEKBI-UHFFFAOYSA-N 0.000 description 1
- 239000008273 gelatin Substances 0.000 description 1
- 229920000159 gelatin Polymers 0.000 description 1
- 235000019322 gelatine Nutrition 0.000 description 1
- 235000011852 gelatine desserts Nutrition 0.000 description 1
- 229940113087 geraniol Drugs 0.000 description 1
- 235000008434 ginseng Nutrition 0.000 description 1
- 229940075507 glyceryl monostearate Drugs 0.000 description 1
- 150000002332 glycine derivatives Chemical class 0.000 description 1
- LPLVUJXQOOQHMX-UHFFFAOYSA-N glycyrrhetinic acid glycoside Natural products C1CC(C2C(C3(CCC4(C)CCC(C)(CC4C3=CC2=O)C(O)=O)C)(C)CC2)(C)C2C(C)(C)C1OC1OC(C(O)=O)C(O)C(O)C1OC1OC(C(O)=O)C(O)C(O)C1O LPLVUJXQOOQHMX-UHFFFAOYSA-N 0.000 description 1
- 239000001685 glycyrrhizic acid Substances 0.000 description 1
- 229960004949 glycyrrhizic acid Drugs 0.000 description 1
- UYRUBYNTXSDKQT-UHFFFAOYSA-N glycyrrhizic acid Natural products CC1(C)C(CCC2(C)C1CCC3(C)C2C(=O)C=C4C5CC(C)(CCC5(C)CCC34C)C(=O)O)OC6OC(C(O)C(O)C6OC7OC(O)C(O)C(O)C7C(=O)O)C(=O)O UYRUBYNTXSDKQT-UHFFFAOYSA-N 0.000 description 1
- 235000019410 glycyrrhizin Nutrition 0.000 description 1
- LPLVUJXQOOQHMX-QWBHMCJMSA-N glycyrrhizinic acid Chemical compound O([C@@H]1[C@@H](O)[C@H](O)[C@H](O[C@@H]1O[C@@H]1C([C@H]2[C@]([C@@H]3[C@@]([C@@]4(CC[C@@]5(C)CC[C@@](C)(C[C@H]5C4=CC3=O)C(O)=O)C)(C)CC2)(C)CC1)(C)C)C(O)=O)[C@@H]1O[C@H](C(O)=O)[C@@H](O)[C@H](O)[C@H]1O LPLVUJXQOOQHMX-QWBHMCJMSA-N 0.000 description 1
- 235000021552 granulated sugar Nutrition 0.000 description 1
- 229960002350 guaiazulen Drugs 0.000 description 1
- 230000023597 hemostasis Effects 0.000 description 1
- 208000006454 hepatitis Diseases 0.000 description 1
- 231100000283 hepatitis Toxicity 0.000 description 1
- 235000001050 hortel pimenta Nutrition 0.000 description 1
- 235000019447 hydroxyethyl cellulose Nutrition 0.000 description 1
- 238000011534 incubation Methods 0.000 description 1
- 230000004968 inflammatory condition Effects 0.000 description 1
- 230000002757 inflammatory effect Effects 0.000 description 1
- 230000003993 interaction Effects 0.000 description 1
- 125000000959 isobutyl group Chemical group [H]C([H])([H])C([H])(C([H])([H])[H])C([H])([H])* 0.000 description 1
- NFLGAXVYCFJBMK-UHFFFAOYSA-N isomenthone Natural products CC(C)C1CCC(C)CC1=O NFLGAXVYCFJBMK-UHFFFAOYSA-N 0.000 description 1
- 125000001449 isopropyl group Chemical group [H]C([H])([H])C([H])(*)C([H])([H])[H] 0.000 description 1
- NLYAJNPCOHFWQQ-UHFFFAOYSA-N kaolin Chemical compound O.O.O=[Al]O[Si](=O)O[Si](=O)O[Al]=O NLYAJNPCOHFWQQ-UHFFFAOYSA-N 0.000 description 1
- 239000008101 lactose Substances 0.000 description 1
- 229960001375 lactose Drugs 0.000 description 1
- AIHDCSAXVMAMJH-GFBKWZILSA-N levan Chemical compound O[C@H]1[C@H](O)[C@@H](CO)O[C@@]1(CO)OC[C@@H]1[C@@H](O)[C@H](O)[C@](CO)(CO[C@@H]2[C@H]([C@H](O)[C@@](O)(CO)O2)O)O1 AIHDCSAXVMAMJH-GFBKWZILSA-N 0.000 description 1
- 229940069445 licorice extract Drugs 0.000 description 1
- 229930007744 linalool Natural products 0.000 description 1
- 229940057995 liquid paraffin Drugs 0.000 description 1
- 239000004325 lysozyme Substances 0.000 description 1
- 235000010335 lysozyme Nutrition 0.000 description 1
- 229960000274 lysozyme Drugs 0.000 description 1
- GVALZJMUIHGIMD-UHFFFAOYSA-H magnesium phosphate Chemical compound [Mg+2].[Mg+2].[Mg+2].[O-]P([O-])([O-])=O.[O-]P([O-])([O-])=O GVALZJMUIHGIMD-UHFFFAOYSA-H 0.000 description 1
- 239000004137 magnesium phosphate Substances 0.000 description 1
- 229910000157 magnesium phosphate Inorganic materials 0.000 description 1
- 229960002261 magnesium phosphate Drugs 0.000 description 1
- 235000010994 magnesium phosphates Nutrition 0.000 description 1
- 239000000391 magnesium silicate Substances 0.000 description 1
- 229910052919 magnesium silicate Inorganic materials 0.000 description 1
- 235000019792 magnesium silicate Nutrition 0.000 description 1
- 229910052943 magnesium sulfate Inorganic materials 0.000 description 1
- 235000019341 magnesium sulphate Nutrition 0.000 description 1
- ZADYMNAVLSWLEQ-UHFFFAOYSA-N magnesium;oxygen(2-);silicon(4+) Chemical compound [O-2].[O-2].[O-2].[Mg+2].[Si+4] ZADYMNAVLSWLEQ-UHFFFAOYSA-N 0.000 description 1
- 239000000845 maltitol Substances 0.000 description 1
- 235000010449 maltitol Nutrition 0.000 description 1
- VQHSOMBJVWLPSR-WUJBLJFYSA-N maltitol Chemical compound OC[C@H](O)[C@@H](O)[C@@H]([C@H](O)CO)O[C@H]1O[C@H](CO)[C@@H](O)[C@H](O)[C@H]1O VQHSOMBJVWLPSR-WUJBLJFYSA-N 0.000 description 1
- 229940035436 maltitol Drugs 0.000 description 1
- 229940099596 manganese sulfate Drugs 0.000 description 1
- 239000011702 manganese sulphate Substances 0.000 description 1
- 235000007079 manganese sulphate Nutrition 0.000 description 1
- SQQMAOCOWKFBNP-UHFFFAOYSA-L manganese(II) sulfate Chemical compound [Mn+2].[O-]S([O-])(=O)=O SQQMAOCOWKFBNP-UHFFFAOYSA-L 0.000 description 1
- 238000004519 manufacturing process Methods 0.000 description 1
- 239000000463 material Substances 0.000 description 1
- 239000001525 mentha piperita l. herb oil Substances 0.000 description 1
- 239000001683 mentha spicata herb oil Substances 0.000 description 1
- 229940041616 menthol Drugs 0.000 description 1
- 230000002503 metabolic effect Effects 0.000 description 1
- 229920000609 methyl cellulose Polymers 0.000 description 1
- 125000002496 methyl group Chemical group [H]C([H])([H])* 0.000 description 1
- 229960001047 methyl salicylate Drugs 0.000 description 1
- 235000010981 methylcellulose Nutrition 0.000 description 1
- 239000001923 methylcellulose Substances 0.000 description 1
- 239000010445 mica Substances 0.000 description 1
- 229910052618 mica group Inorganic materials 0.000 description 1
- 239000004200 microcrystalline wax Substances 0.000 description 1
- 235000019808 microcrystalline wax Nutrition 0.000 description 1
- 229940114937 microcrystalline wax Drugs 0.000 description 1
- 238000002156 mixing Methods 0.000 description 1
- XONPDZSGENTBNJ-UHFFFAOYSA-N molecular hydrogen;sodium Chemical compound [Na].[H][H] XONPDZSGENTBNJ-UHFFFAOYSA-N 0.000 description 1
- 239000001788 mono and diglycerides of fatty acids Substances 0.000 description 1
- 229910000403 monosodium phosphate Inorganic materials 0.000 description 1
- 235000019799 monosodium phosphate Nutrition 0.000 description 1
- 229940023607 myristic acid Drugs 0.000 description 1
- 239000012454 non-polar solvent Substances 0.000 description 1
- 239000003921 oil Substances 0.000 description 1
- 235000019198 oils Nutrition 0.000 description 1
- 239000003960 organic solvent Substances 0.000 description 1
- TWNQGVIAIRXVLR-UHFFFAOYSA-N oxo(oxoalumanyloxy)alumane Chemical compound O=[Al]O[Al]=O TWNQGVIAIRXVLR-UHFFFAOYSA-N 0.000 description 1
- 235000019477 peppermint oil Nutrition 0.000 description 1
- 235000019319 peptone Nutrition 0.000 description 1
- 239000003208 petroleum Substances 0.000 description 1
- 230000000144 pharmacologic effect Effects 0.000 description 1
- OQUKIQWCVTZJAF-UHFFFAOYSA-N phenol;sulfuric acid Chemical compound OS(O)(=O)=O.OC1=CC=CC=C1 OQUKIQWCVTZJAF-UHFFFAOYSA-N 0.000 description 1
- 229940067107 phenylethyl alcohol Drugs 0.000 description 1
- 239000010452 phosphate Substances 0.000 description 1
- 229960004838 phosphoric acid Drugs 0.000 description 1
- PJNZPQUBCPKICU-UHFFFAOYSA-N phosphoric acid;potassium Chemical compound [K].OP(O)(O)=O PJNZPQUBCPKICU-UHFFFAOYSA-N 0.000 description 1
- 239000002504 physiological saline solution Substances 0.000 description 1
- 239000000419 plant extract Substances 0.000 description 1
- 239000002798 polar solvent Substances 0.000 description 1
- 229920001495 poly(sodium acrylate) polymer Polymers 0.000 description 1
- 229920001223 polyethylene glycol Polymers 0.000 description 1
- 229940093430 polyethylene glycol 1500 Drugs 0.000 description 1
- 229940068918 polyethylene glycol 400 Drugs 0.000 description 1
- 229940057847 polyethylene glycol 600 Drugs 0.000 description 1
- 229940093429 polyethylene glycol 6000 Drugs 0.000 description 1
- 229920000642 polymer Polymers 0.000 description 1
- 235000010486 polyoxyethylene sorbitan monolaurate Nutrition 0.000 description 1
- 239000000256 polyoxyethylene sorbitan monolaurate Substances 0.000 description 1
- 235000010482 polyoxyethylene sorbitan monooleate Nutrition 0.000 description 1
- 239000000244 polyoxyethylene sorbitan monooleate Substances 0.000 description 1
- 235000010483 polyoxyethylene sorbitan monopalmitate Nutrition 0.000 description 1
- 239000000249 polyoxyethylene sorbitan monopalmitate Substances 0.000 description 1
- 229920000053 polysorbate 80 Polymers 0.000 description 1
- 239000001267 polyvinylpyrrolidone Substances 0.000 description 1
- 229920000036 polyvinylpyrrolidone Polymers 0.000 description 1
- 235000013855 polyvinylpyrrolidone Nutrition 0.000 description 1
- 230000008092 positive effect Effects 0.000 description 1
- 239000004302 potassium sorbate Substances 0.000 description 1
- 235000010241 potassium sorbate Nutrition 0.000 description 1
- 229940069338 potassium sorbate Drugs 0.000 description 1
- 238000002360 preparation method Methods 0.000 description 1
- 239000003755 preservative agent Substances 0.000 description 1
- 230000003449 preventive effect Effects 0.000 description 1
- 239000003380 propellant Substances 0.000 description 1
- 125000001436 propyl group Chemical group [H]C([*])([H])C([H])([H])C([H])([H])[H] 0.000 description 1
- 102000004169 proteins and genes Human genes 0.000 description 1
- 108090000623 proteins and genes Proteins 0.000 description 1
- 238000000746 purification Methods 0.000 description 1
- ZUFQODAHGAHPFQ-UHFFFAOYSA-N pyridoxine hydrochloride Chemical compound Cl.CC1=NC=C(CO)C(CO)=C1O ZUFQODAHGAHPFQ-UHFFFAOYSA-N 0.000 description 1
- 229960004172 pyridoxine hydrochloride Drugs 0.000 description 1
- 235000019171 pyridoxine hydrochloride Nutrition 0.000 description 1
- 239000011764 pyridoxine hydrochloride Substances 0.000 description 1
- 150000003856 quaternary ammonium compounds Chemical class 0.000 description 1
- HELXLJCILKEWJH-NCGAPWICSA-N rebaudioside A Chemical compound O([C@H]1[C@H](O)[C@@H](CO)O[C@H]([C@@H]1O[C@H]1[C@@H]([C@@H](O)[C@H](O)[C@@H](CO)O1)O)O[C@]12C(=C)C[C@@]3(C1)CC[C@@H]1[C@@](C)(CCC[C@]1([C@@H]3CC2)C)C(=O)O[C@H]1[C@@H]([C@@H](O)[C@H](O)[C@@H](CO)O1)O)[C@@H]1O[C@H](CO)[C@@H](O)[C@H](O)[C@H]1O HELXLJCILKEWJH-NCGAPWICSA-N 0.000 description 1
- 230000002829 reductive effect Effects 0.000 description 1
- 238000011160 research Methods 0.000 description 1
- 229940085605 saccharin sodium Drugs 0.000 description 1
- 229940112950 sage extract Drugs 0.000 description 1
- 235000020752 sage extract Nutrition 0.000 description 1
- 210000003296 saliva Anatomy 0.000 description 1
- 238000005185 salting out Methods 0.000 description 1
- 150000003839 salts Chemical class 0.000 description 1
- 108700004121 sarkosyl Proteins 0.000 description 1
- 239000000932 sedative agent Substances 0.000 description 1
- 230000001624 sedative effect Effects 0.000 description 1
- 239000000377 silicon dioxide Substances 0.000 description 1
- 239000000344 soap Substances 0.000 description 1
- 235000010413 sodium alginate Nutrition 0.000 description 1
- 239000000661 sodium alginate Substances 0.000 description 1
- 229940005550 sodium alginate Drugs 0.000 description 1
- 229960003885 sodium benzoate Drugs 0.000 description 1
- 229940080236 sodium cetyl sulfate Drugs 0.000 description 1
- 239000001509 sodium citrate Substances 0.000 description 1
- NLJMYIDDQXHKNR-UHFFFAOYSA-K sodium citrate Chemical compound O.O.[Na+].[Na+].[Na+].[O-]C(=O)CC(O)(CC([O-])=O)C([O-])=O NLJMYIDDQXHKNR-UHFFFAOYSA-K 0.000 description 1
- 229960001790 sodium citrate Drugs 0.000 description 1
- 235000011083 sodium citrates Nutrition 0.000 description 1
- 235000013758 sodium copper chlorophyllin Nutrition 0.000 description 1
- 229940079841 sodium copper chlorophyllin Drugs 0.000 description 1
- 235000019259 sodium dehydroacetate Nutrition 0.000 description 1
- 229940079839 sodium dehydroacetate Drugs 0.000 description 1
- AJPJDKMHJJGVTQ-UHFFFAOYSA-M sodium dihydrogen phosphate Chemical compound [Na+].OP(O)([O-])=O AJPJDKMHJJGVTQ-UHFFFAOYSA-M 0.000 description 1
- FQENQNTWSFEDLI-UHFFFAOYSA-J sodium diphosphate Chemical compound [Na+].[Na+].[Na+].[Na+].[O-]P([O-])(=O)OP([O-])([O-])=O FQENQNTWSFEDLI-UHFFFAOYSA-J 0.000 description 1
- 229940073490 sodium glutamate Drugs 0.000 description 1
- 229940083608 sodium hydroxide Drugs 0.000 description 1
- 239000001540 sodium lactate Substances 0.000 description 1
- 235000011088 sodium lactate Nutrition 0.000 description 1
- 229940005581 sodium lactate Drugs 0.000 description 1
- KSAVQLQVUXSOCR-UHFFFAOYSA-M sodium lauroyl sarcosinate Chemical compound [Na+].CCCCCCCCCCCC(=O)N(C)CC([O-])=O KSAVQLQVUXSOCR-UHFFFAOYSA-M 0.000 description 1
- 229940045885 sodium lauroyl sarcosinate Drugs 0.000 description 1
- 229960004711 sodium monofluorophosphate Drugs 0.000 description 1
- 239000001488 sodium phosphate Substances 0.000 description 1
- NNMHYFLPFNGQFZ-UHFFFAOYSA-M sodium polyacrylate Chemical compound [Na+].[O-]C(=O)C=C NNMHYFLPFNGQFZ-UHFFFAOYSA-M 0.000 description 1
- 235000019830 sodium polyphosphate Nutrition 0.000 description 1
- 229940048086 sodium pyrophosphate Drugs 0.000 description 1
- NTHWMYGWWRZVTN-UHFFFAOYSA-N sodium silicate Chemical compound [Na+].[Na+].[O-][Si]([O-])=O NTHWMYGWWRZVTN-UHFFFAOYSA-N 0.000 description 1
- DSOWAKKSGYUMTF-GZOLSCHFSA-M sodium;(1e)-1-(6-methyl-2,4-dioxopyran-3-ylidene)ethanolate Chemical compound [Na+].C\C([O-])=C1/C(=O)OC(C)=CC1=O DSOWAKKSGYUMTF-GZOLSCHFSA-M 0.000 description 1
- GGHPAKFFUZUEKL-UHFFFAOYSA-M sodium;hexadecyl sulfate Chemical compound [Na+].CCCCCCCCCCCCCCCCOS([O-])(=O)=O GGHPAKFFUZUEKL-UHFFFAOYSA-M 0.000 description 1
- 238000000638 solvent extraction Methods 0.000 description 1
- 235000010199 sorbic acid Nutrition 0.000 description 1
- 239000004334 sorbic acid Substances 0.000 description 1
- 229940075582 sorbic acid Drugs 0.000 description 1
- 229940035044 sorbitan monolaurate Drugs 0.000 description 1
- 235000011069 sorbitan monooleate Nutrition 0.000 description 1
- 239000001593 sorbitan monooleate Substances 0.000 description 1
- 229940035049 sorbitan monooleate Drugs 0.000 description 1
- 229960002920 sorbitol Drugs 0.000 description 1
- 235000019721 spearmint oil Nutrition 0.000 description 1
- 239000007921 spray Substances 0.000 description 1
- 238000001256 steam distillation Methods 0.000 description 1
- 239000000126 substance Substances 0.000 description 1
- 150000008163 sugars Chemical class 0.000 description 1
- QAOWNCQODCNURD-UHFFFAOYSA-N sulfuric acid Substances OS(O)(=O)=O QAOWNCQODCNURD-UHFFFAOYSA-N 0.000 description 1
- 239000003765 sweetening agent Substances 0.000 description 1
- 230000008961 swelling Effects 0.000 description 1
- 239000000454 talc Substances 0.000 description 1
- 229910052623 talc Inorganic materials 0.000 description 1
- 229940033134 talc Drugs 0.000 description 1
- 235000012222 talc Nutrition 0.000 description 1
- 239000003760 tallow Substances 0.000 description 1
- 239000011975 tartaric acid Substances 0.000 description 1
- 235000002906 tartaric acid Nutrition 0.000 description 1
- 235000019818 tetrasodium diphosphate Nutrition 0.000 description 1
- 239000001577 tetrasodium phosphonato phosphate Substances 0.000 description 1
- UEUXEKPTXMALOB-UHFFFAOYSA-J tetrasodium;2-[2-[bis(carboxylatomethyl)amino]ethyl-(carboxylatomethyl)amino]acetate Chemical compound [Na+].[Na+].[Na+].[Na+].[O-]C(=O)CN(CC([O-])=O)CCN(CC([O-])=O)CC([O-])=O UEUXEKPTXMALOB-UHFFFAOYSA-J 0.000 description 1
- 239000002562 thickening agent Substances 0.000 description 1
- 239000010409 thin film Substances 0.000 description 1
- 229960000790 thymol Drugs 0.000 description 1
- 239000010936 titanium Substances 0.000 description 1
- 229910052719 titanium Inorganic materials 0.000 description 1
- 239000004408 titanium dioxide Substances 0.000 description 1
- 229960005196 titanium dioxide Drugs 0.000 description 1
- OGIDPMRJRNCKJF-UHFFFAOYSA-N titanium oxide Inorganic materials [Ti]=O OGIDPMRJRNCKJF-UHFFFAOYSA-N 0.000 description 1
- GYDJEQRTZSCIOI-LJGSYFOKSA-N tranexamic acid Chemical compound NC[C@H]1CC[C@H](C(O)=O)CC1 GYDJEQRTZSCIOI-LJGSYFOKSA-N 0.000 description 1
- 229960000401 tranexamic acid Drugs 0.000 description 1
- RYFMWSXOAZQYPI-UHFFFAOYSA-K trisodium phosphate Chemical compound [Na+].[Na+].[Na+].[O-]P([O-])([O-])=O RYFMWSXOAZQYPI-UHFFFAOYSA-K 0.000 description 1
- 229910000406 trisodium phosphate Inorganic materials 0.000 description 1
- 235000019801 trisodium phosphate Nutrition 0.000 description 1
- 241001148471 unidentified anaerobic bacterium Species 0.000 description 1
- 230000024883 vasodilation Effects 0.000 description 1
- 235000019165 vitamin E Nutrition 0.000 description 1
- 229940046009 vitamin E Drugs 0.000 description 1
- 239000011709 vitamin E Substances 0.000 description 1
- 238000003809 water extraction Methods 0.000 description 1
- 239000010497 wheat germ oil Substances 0.000 description 1
- 239000000230 xanthan gum Substances 0.000 description 1
- 235000010493 xanthan gum Nutrition 0.000 description 1
- 229920001285 xanthan gum Polymers 0.000 description 1
- 229940082509 xanthan gum Drugs 0.000 description 1
- 239000011592 zinc chloride Substances 0.000 description 1
- 235000005074 zinc chloride Nutrition 0.000 description 1
- UHVMMEOXYDMDKI-JKYCWFKZSA-L zinc;1-(5-cyanopyridin-2-yl)-3-[(1s,2s)-2-(6-fluoro-2-hydroxy-3-propanoylphenyl)cyclopropyl]urea;diacetate Chemical compound [Zn+2].CC([O-])=O.CC([O-])=O.CCC(=O)C1=CC=C(F)C([C@H]2[C@H](C2)NC(=O)NC=2N=CC(=CC=2)C#N)=C1O UHVMMEOXYDMDKI-JKYCWFKZSA-L 0.000 description 1
- 229930007845 β-thujaplicin Natural products 0.000 description 1
Abstract
Description
【発明の詳細な説明】
〈産業上の利用分野〉
本発明は酵素阻害剤及び口腔用組成物に関し、特にシャ
クヤク、ビワヨウ、ジヨウインチン、チユから選ばれる
植物の溶媒抽出物を含有する口腔用組成物に関する。[Detailed Description of the Invention] <Industrial Application Field> The present invention relates to an enzyme inhibitor and an oral composition, and more particularly to an oral composition containing a solvent extract of a plant selected from Peony, Biwayoum, J. chinensis, and Chiyu. Regarding.
〈従来技術〉
歯の表面に付着する歯垢は、その約3分の2が微生物か
らなりこれら微生物叢の多様な代謝活性を通じて口腔に
対して悪影響を与える。即ち、歯垢は歯科における二人
疾患といわれる虫歯(う蝕)や歯周病(歯槽膿漏など)
の元凶となっているだけでなく、口臭の原因となる嫌気
性細菌の温床にもなる。この歯垢の形成においては歯の
エナメル質表面に唾液中の糖タンパク質が付着しペリク
ルと呼ばれる薄い被膜(厚さ約1μ)を形成し、虫歯の
原因菌の1つであるストレプトコッカスミュータンス(
Streptococcus mutans)の菌体
表層物質とペリクルとの相互作用によりストレプトコッ
カスミュータンスが付着する。次にストレプトコッカス
ミュータンスからの特有な不溶性グルカンを介した付着
をする。この不溶性グルカンは1種の接着剤のような性
質を持っており、前記の不溶性グルカンを有しない付着
で、弱く付着したストレプトコッカスミュータンスに加
え多くの細菌などを包含した形で強固に付着し歯垢を形
成する。この不溶性グルカンはα(1→3)グリコシド
結合を主鎖とし、α(1→゛6)グリコシド結合の側鎖
を有し、口腔内に存在するショ糖を利用して形成される
。この時にはストレプトコッカスミュータンスが有する
グルコシルトランスフェラーゼ(デキストラン合成酵素
二重下GTFという)が関与し、不溶性デキストランと
してムタンあるいはレバンなどが作られる。<Prior Art> Approximately two-thirds of the dental plaque that adheres to the surface of teeth is composed of microorganisms, and has an adverse effect on the oral cavity through the various metabolic activities of these microorganisms. In other words, dental plaque can cause tooth decay (caries) and periodontal disease (alveolar pyorrhea, etc.), which are said to be two diseases in dentistry.
Not only is it the culprit for bad breath, it is also a breeding ground for anaerobic bacteria that cause bad breath. In the formation of this dental plaque, glycoproteins in saliva adhere to the tooth enamel surface and form a thin film (approximately 1 μm in thickness) called a pellicle, which causes Streptococcus mutans (
Streptococcus mutans adheres due to the interaction between the bacterial cell surface substance and the pellicle. It then attaches via a unique insoluble glucan from Streptococcus mutans. This insoluble glucan has properties like a kind of adhesive, and it adheres strongly to the tooth, containing many bacteria in addition to the weakly attached Streptococcus mutans, which does not have the above-mentioned insoluble glucan. Forms dirt. This insoluble glucan has a main chain of α(1→3) glycosidic bonds, a side chain of α(1→゛6) glycosidic bonds, and is formed using sucrose present in the oral cavity. At this time, glucosyltransferase (referred to as dextran synthase double-subordinate GTF) possessed by Streptococcus mutans is involved, and mutan or levan is produced as an insoluble dextran.
GTFは近年ようやく精製法が確立し、血清型d/g/
mのストレプトコッカスミュータンスは3−4種のGT
Fを産生ずることが確認されこれらの1種は不溶性グル
カンを合成する酵素で残りは水溶性グルカンを合成する
酵素で有ることがわかってきた。A purification method for GTF has finally been established in recent years, and the serotype d/g/
Streptococcus mutans of m is 3-4 species of GT
It has been confirmed that one of these enzymes is an enzyme that synthesizes insoluble glucan, and the rest are enzymes that synthesize water-soluble glucan.
そして抗GTF作用及び不溶性グルカンの分解を目的と
した方法としては歯に付着した糖類(不溶性グルカン等
)を分解するためにα(1→3)グルカナーゼやムタス
テインなどの酵素を添加した口腔組成物あるいはチユー
インガムが開発されると共に、生薬成分である植物(例
えば玄草なと)から有機溶媒を用いて抽出された抽出物
(特開昭57−5861o号、特開昭61−26001
2号)あルイハスリランカで用いられるアーユルベーダ
薬草より水または低級アルコールにより抽出された抽出
物(特開昭60−54312号)の抗GTF作用ついて
研究されてきた。Methods aimed at anti-GTF action and decomposition of insoluble glucan include oral compositions containing enzymes such as α(1→3) glucanase and mutastein to decompose sugars (insoluble glucans, etc.) attached to teeth; Along with the development of chewing gum, extracts extracted from plants (e.g. Genso nato) using organic solvents (JP-A-57-5861O, JP-A-61-26001) were developed.
No. 2) The anti-GTF effect of an extract extracted with water or lower alcohol from an Ayurvedic medicinal herb used in Sri Lanka (Japanese Patent Application Laid-Open No. 60-54312) has been studied.
生薬に関する抗GTF作用については、前記のように多
くの研究が成されているが全ての生薬について行われた
わけではない。シャクヤクについては既に鎮静、鎮痛、
鎮痙、抗炎症、血圧下降、血管拡張等の薬理作用が確認
され、鎮痙、鎮痛、緩和、収れんの各用途に用いられる
。またビワヨウは鎮咳、去痰、上湯等の用途、ジヨウイ
ンチンは杭機、駆虫作用のほか利胆作用を有し、肝炎、
黄喧、じん麻疹、むくみなどに用いられたり、炎症性利
尿、利胆薬としても用いられ、チユは収れん、止血、上
湯、鎮痛、消炎等の用途に用いられて来た。As mentioned above, many studies have been conducted on the anti-GTF effects of crude drugs, but not all of them have been studied. Peonies are already known for their sedative, analgesic, and
It has been confirmed to have pharmacological effects such as antispasmodic, anti-inflammatory, blood pressure lowering, and vasodilation, and is used for antispasmodic, analgesic, relaxation, and astringent purposes. In addition, Biwayo is used as an antitussive, expectorant, hot water, etc., and Jiyouintin is used as a piling agent, anthelmintic, and has a choleretic effect, and is used to treat hepatitis,
It has been used to treat inflammatory conditions, hives, and swelling, as well as as an inflammatory diuretic and choleretic, and chuyu has been used for purposes such as astringency, hemostasis, hot water, analgesia, and anti-inflammation.
〈発明が解決しようとする問題点〉
しかし、従来より各種の用途に用いられてきた生薬につ
いて抗GTF作用に関する研究は今だ充分とはいいがた
い。そこで更に多種類の生薬についてストレプトコッカ
スミュータンスの抗GTF作用について検討した結果、
新たにシャクヤク、ビワヨウ、ショウインチン、チユに
ついて抗GTF活性を有することを発見した。つまりシ
ャクヤク、ビワヨウ、シュウインチン、チユの植物の溶
媒抽出物がストレプトコッカスミュータンスによる歯垢
形成を抑制し、虫歯あるいは歯周病の予防に好適であり
、該溶媒抽出物により虫歯等の予防に有用な酵素阻害剤
を発明した。<Problems to be solved by the invention> However, research on the anti-GTF effects of crude drugs that have been used for various purposes is still insufficient. Therefore, as a result of further investigating the anti-GTF effect of Streptococcus mutans on a wide variety of herbal medicines,
It has been newly discovered that peony, chinensis, chinensis, and chinensis have anti-GTF activity. In other words, solvent extracts of plants such as Peony, Biwayo, Shuinchin, and Chiyu suppress plaque formation caused by Streptococcus mutans and are suitable for preventing tooth decay or periodontal disease; Invented a new enzyme inhibitor.
〈問題を解決するための手段〉
本発明はシャクヤク、ビワヨウ、ジヨウインチン、チユ
から選ばれる植物の溶媒抽出物の1種または2種以上を
含有することを特徴とする酵素阻害剤及び上記酵素阻害
剤を有効成分として含有することを特徴とする口腔用組
成物に係る。<Means for Solving the Problems> The present invention provides an enzyme inhibitor characterized by containing one or more solvent extracts of plants selected from Peony, Biwayo, J. chinensis, and Chiyu, and the above-mentioned enzyme inhibitor. It relates to an oral composition characterized by containing as an active ingredient.
本発明にかかる酵素阻害剤は練歯磨、粉歯磨、水歯磨、
マウスウォシュ、トローチ、錠剤、粉粒剤、塗布剤、含
そう剤、口中清涼剤、チユーインガム、ドリンク剤、キ
ャンデー等として使用されるもので有効成分としてはシ
ャクヤク、ビワヨウ、ショウインチン、チユから選ばれ
る植物の溶媒抽出物の1種または2種以上を配合してな
るものである。The enzyme inhibitor according to the present invention includes toothpaste, toothpaste, water toothpaste,
Used as mouthwashes, troches, tablets, powders, liniments, mouthwashes, mouth fresheners, chewing gum, drinks, candies, etc.The active ingredients are selected from peony, loquat, shoinchin, and chuyu. It is made by blending one or more kinds of solvent extracts of plants.
前記植物の抽出に用いる溶媒としては水、アルコールア
セトン、エチルエーテル、酢酸エチルなどの極性溶媒、
ベンゼン、ヘキサン、石油エーテル等の非極性溶媒が使
用でき、含水アルコール等の混合溶媒も使用し得る。特
にアルコールとしては主に低級アルコールで炭素数1か
ら5までのアルコールが例示でき、例えばメチルアルコ
ール、エチルアルコール、プロピルアルコール、イソプ
ロピルアルコール、ブチルアルコール、アミルアルコー
ルなどがある。Solvents used for extracting the plants include water, polar solvents such as alcohol acetone, ethyl ether, and ethyl acetate;
Non-polar solvents such as benzene, hexane and petroleum ether can be used, and mixed solvents such as hydrous alcohols can also be used. In particular, alcohols include lower alcohols having 1 to 5 carbon atoms, such as methyl alcohol, ethyl alcohol, propyl alcohol, isopropyl alcohol, butyl alcohol, and amyl alcohol.
含水アルコールとしては含水メチルアルコール、含水エ
チルアルコールなどが例示でき、これらは1種または2
種以上の混合物としても使用しうる。Examples of hydrous alcohols include hydrous methyl alcohol and hydrous ethyl alcohol, which may be used in combination of one or two types.
It can also be used as a mixture of more than one species.
これらの溶媒のうちエチルアルコール、水、またはこれ
らの混合溶媒は、従来行われている人体に良い影響を与
えない溶媒を減圧濃縮などの操作により除去する工程を
、場合においては簡略化でき好ましい。そしてこの様な
溶媒を用いた場合、誤飲等に対しても安全性の高い組成
物を作り得る。Among these solvents, ethyl alcohol, water, or a mixed solvent thereof is preferable because it can simplify the conventional process of removing solvents that do not have a positive effect on the human body by operations such as vacuum concentration. When such a solvent is used, it is possible to create a composition that is highly safe against accidental ingestion.
本発明において有効成分として用いる溶媒抽出物は上記
植物の1種または2種以上を前記溶媒の1種または2種
以上の混合溶媒を用いて抽出し、その抽出物より残さを
除去したものを用い得る。The solvent extract used as an active ingredient in the present invention is obtained by extracting one or more of the above-mentioned plants using one or more of the above-mentioned solvents and removing the residue from the extract. obtain.
抽出方法としては水蒸気蒸留など従来からの各種の方法
が採用できるだけでなく、該植物を溶媒中に長時間浸漬
するだけでも行いえる。また、該植物はそのまま抽出に
使用しても良いが、破砕あるいは粉末とした後、使用し
た場合抽出効率が良い。As the extraction method, not only various conventional methods such as steam distillation can be used, but also simply immersing the plant in a solvent for a long time. Further, the plant may be used for extraction as it is, but the extraction efficiency is better if it is used after being crushed or powdered.
既に述べた各植物の抗GTF作用を、以下の試験例に基
づき詳細に説明する。また、対照としての植物としては
従来より溶媒抽出物が抗GTF作用を有するとされてい
るゲンソウ(玄草)を用いた。The anti-GTF effect of each plant mentioned above will be explained in detail based on the following test examples. Furthermore, as a control plant, Gensou (Genso), whose solvent extract has been known to have an anti-GTF effect, was used.
試験例
1、植物の溶媒抽出物の効果
以下に記載の方法により植物の溶媒抽出物の製造、検定
用GTFの調製を行い、各溶媒抽出液の抗GTF効果を
不溶性グルカン付着阻害試験にて測定した。Test Example 1: Effect of solvent extracts of plants A solvent extract of plants was produced and GTF for testing was prepared by the method described below, and the anti-GTF effect of each solvent extract was measured by an insoluble glucan adhesion inhibition test. did.
そして、不溶性グルカン量はグルコース換算で示し、付
着阻害率は植物の抽出液を添加しない対照の不溶性グル
カン付着量を100%とした場合の百分率で示した。ま
た表中のカッコ内に各植物を抽出するのに用いた溶媒を
記載した。なお植物の水抽出液に対する対照は該植物の
水抽出液の換わりに水を、植物の工Iダノール抽出液に
対する対照は該植物のエタノール抽出液の換わりにエタ
ノールを添加した。The amount of insoluble glucan was expressed in terms of glucose, and the rate of inhibition of adhesion was expressed as a percentage, with the amount of insoluble glucan attached in a control to which no plant extract was added as 100%. In addition, the solvent used to extract each plant is listed in parentheses in the table. Note that for the control for the aqueous extract of the plant, water was added instead of the aqueous extract of the plant, and for the control for the danol extract of the plant, ethanol was added instead of the ethanol extract of the plant.
1)溶媒抽出物の製造:植物の乾燥粉砕物250■に精
製水(3−)またはエタノール(1,5ΩM)を加え充
分撹拌した後、72時間浸漬した(その間24時間ごと
に撹拌を行った)。次いで3000rpmで5分間遠心
分離し、その上清を採取し溶媒抽出物とした。1) Production of solvent extract: Purified water (3-) or ethanol (1.5 ΩM) was added to 250 μm of dried pulverized plant material, thoroughly stirred, and then immersed for 72 hours (during which time stirring was performed every 24 hours). ). The mixture was then centrifuged at 3000 rpm for 5 minutes, and the supernatant was collected and used as a solvent extract.
2)検定用GTFの調製:ストレプトコッカスミュータ
ンスOMZ 176株をバーマン(Berman)培地
(トリプトケースペプトン(B B L社製)2%(以
下重量/体積百分率)、グルコース 0. 1%、リン
酸2水素カリウム 0.1%、リン酸水素カリウム 0
.4%、塩化ナトリウム 0. 2%、硫酸マグネシウ
ム 0.012%、硫酸マンガン 0゜0015%、I
)H7,4)300amに接種し恒温室で37℃、24
時間培養後15000gで20分間遠心分離を行い上清
を得た。この上清に対して60%飽和硫安塩析(室温で
20時間)を行い上滑中のタンパク質を沈殿させ、60
00gで30分間遠心分離を行ない沈でん物を得た。沈
でん物を0.01Mリン酸緩衝液(pH6,5)に溶解
し透析を0゜01Mリン酸緩衝液(pH6,5)に対し
て3同行い検定用GTFを得た。そして、該検定用GT
Fは少量ずつ分注した後−20℃にて凍結保存し検定時
に水中で溶解した。2) Preparation of GTF for assay: Streptococcus mutans OMZ 176 strain was cultured in Berman medium (tryptocase peptone (manufactured by BBL) 2% (hereinafter referred to as weight/volume percentage), glucose 0.1%, phosphoric acid Potassium dihydrogen 0.1%, potassium hydrogen phosphate 0
.. 4%, sodium chloride 0. 2%, magnesium sulfate 0.012%, manganese sulfate 0°0015%, I
)H7,4) Inoculated at 300am and incubated at 37℃ in a constant temperature room for 24 hours.
After incubation for an hour, centrifugation was performed at 15,000 g for 20 minutes to obtain a supernatant. This supernatant was subjected to 60% saturated ammonium sulfate salting out (20 hours at room temperature) to precipitate the proteins in the supernatant.
Centrifugation was performed at 00g for 30 minutes to obtain a precipitate. The precipitate was dissolved in 0.01M phosphate buffer (pH 6.5) and dialyzed three times against 0.01M phosphate buffer (pH 6.5) to obtain GTF for assay. And the GT for the test
F was dispensed into small portions, stored frozen at -20°C, and dissolved in water at the time of assay.
3)付着阻害試験=96穴マイクロプレート(塩化ビニ
ル製)を用いて行った。プレート中に10%ショ糖を含
むO,1Mリン酸緩衝液(pH6,0)204、溶媒抽
出物(濃度3%)5−及び検定用GTF25−を加え、
37℃、16時間静置する。ウェル中の反応液を除去し
た後プレートを生理食塩水(1Ω)中にゆっくり浸漬し
、2〜3回振り洗浄する。各ウェルに0.5N水酸化ナ
トリウム100dを加え不溶性グルカンを溶解し、フェ
ノール硫酸法で糖量を測定し付着した不溶性グルカン量
を算出した。すなわち、0.5N水酸化ナトリウム溶解
液40−に精製水400−および5%フェノール溶液2
00−を加え、撹拌した後濃硫酸l−を加えて水冷30
分後に490nmで吸光度を測定した。3) Adhesion inhibition test: Conducted using a 96-well microplate (made of vinyl chloride). Add O, 1M phosphate buffer (pH 6,0) 204 containing 10% sucrose, solvent extract (concentration 3%) 5- and GTF 25- for assay into the plate,
Leave at 37°C for 16 hours. After removing the reaction solution in the wells, the plate is slowly immersed in physiological saline (1Ω) and washed by shaking 2 to 3 times. 100 d of 0.5N sodium hydroxide was added to each well to dissolve insoluble glucan, and the amount of sugar was measured by the phenol-sulfuric acid method to calculate the amount of attached insoluble glucan. That is, 40 parts of a 0.5N sodium hydroxide solution, 40 parts of purified water, and 2 parts of a 5% phenol solution.
After stirring, add concentrated sulfuric acid and cool with water for 30 minutes.
Absorbance was measured at 490 nm after minutes.
結果を第1表に示した。The results are shown in Table 1.
(以下余白)
ヨウ、ジヨウインチン、チユの抗GTF作用は、歯垢の
形成を阻害する事において極めて有効であり、虫歯ある
いは歯周病疾患の予防剤として有用である。(Margins below) The anti-GTF action of yaw, chinensis, and zhu is extremely effective in inhibiting the formation of dental plaque, and is useful as a preventive agent for dental caries or periodontal disease.
本発明における溶媒抽出物を活性成分とする酵素阻害剤
の口腔用組成物に対する配合量は、抽出方法により有効
成分としての溶媒抽出物の効果がことなるため一定でな
いが、前記植物を水またはエチルアルコール中(例えば
水が溶媒の場合、水に重量部に対して植物1重量部、ま
たはエチルアルコールが溶媒の場合エチルアルコール5
.8重量部に対し植物1重量部)に72時間浸漬する方
法により抽出した溶媒抽出物を用いた場合、全体の0.
1〜5%(重量%、以下同じ)、特に1〜3%とするの
が好ましい。The amount of the enzyme inhibitor containing a solvent extract as an active ingredient in the oral composition of the present invention is not fixed because the effect of the solvent extract as an active ingredient varies depending on the extraction method. in alcohol (for example, if water is the solvent, 1 part by weight of plant to part by weight of water, or if ethyl alcohol is the solvent, 5 parts by weight of ethyl alcohol)
.. When using a solvent extract obtained by immersing 8 parts by weight of plants in 1 part by weight of plants for 72 hours, the total amount of 0.
It is preferably 1 to 5% (by weight, the same hereinafter), particularly 1 to 3%.
本発明の他の成分としては口腔用組成物の種類により適
宜な成分が用いられる。例えば練歯磨、粉歯磨、水歯磨
、マウスウォッシュなどの歯磨においては研磨剤、粘結
剤、粘稠剤、発泡剤、香料、甘味料、防腐剤等が添加で
き成分としては、ゲラニオール変性アルコール、へアセ
チル化しよ糖変性アルコール、フェニールエチルアルコ
ール変性アルコール、ブルシン変性アルコール、リナロ
ール変性アルコール、ジエチルフタレート変性アルコー
ル、リナリールアセテー上変性アルコール、ベンジルア
セテート変性アルコール、10%安息香酸デナトニウム
アルコール溶液変性アルコール、N−アシル−L−グル
タミン酸ナトリウム、アスコルビン酸、アラントインク
ロルヒドロキシアルミニウム、アルギン酸ナトリウム、
アロエエキス、安息香酸、安息香酸ナトリウム、雲母チ
タン、エタノール、エチレンジアミンテトラポリオキシ
エチレンポリオキシブロビレン、エデト酸二ナトリウム
、エデト酸四ナトリウムニ水塩、塩化亜鉛、塩化ナトリ
ウム、塩酸アルキルジアミノエチルグリシン、塩酸クロ
ルヘキシジン、塩酸ピリドキシン、オイゲノール、オウ
ゴンエキス、γ−オリザノール、カオリン、褐藻エキス
、カラギーナン、カルボキシビニルポリマー、カルボキ
シメチルセルロースナトリウム、含水無晶形酸化ケイ素
、カンゾウエキス、乾燥水酸化アルミニウムゲル、カン
テン、希塩酸、キサンタンガム、グアイアズレン、クエ
ン酸、クエン酸ナトリウム、グリセリン、グリチルリチ
ン酸及びその塩類、グルコン酸クロルヘキシジン、グン
ジョウ、ケイ酸アルミニウムマグネシウム、ケイ酸ナト
リウム、軽質炭酸カルシウム、ケイ皮アルコール、ケイ
皮アルデヒド、結晶セルロース、N−硬化牛脂脂肪酸ア
シル−L−グルタミン酸ナトリウム、合成ケイ酸ナトリ
ウム・マグネシウム、小麦胚芽油、サッカリン、サッカ
リンナトリウム、サリチル酸メチル、酸化アルミニウム
、酸化チタン、シコンエキス、重質炭酸カルシウム、酒
石酸、蒸留ハツカ水、ショ糖脂肪酸エステル、新油型モ
ノステアリン酸グリセリン、水酸化アルミニウム、水酸
化ナトリウム、N−ステアロイル−L−グルタミン酸ナ
トリウム、ステビアエキス、スペアミント油、精製水、
セージエキス、セチル硫酸ナトリウム、石けん用素地、
ゼラチン、線維素グリコール酸ナトリウム、ソルビット
、ソルビン酸カリウム、タルク、炭酸水素ナトリウム、
チモール、デヒドロ酢酸ナトリウム、銅クロロフイリン
ナトリウム、乳酸ナトリウム、乳糖、グリセリン、白糖
、ハツカ油、歯磨用リン酸水素カルシウム、パラオキシ
安息香酸イソブチル、パラオキシ安息香酸イソプロピル
、パラオキシ安息香酸エチル、パラオキシ安息香酸ブチ
ル、パラオキシ安息香酸プロピル、パラオキシ安息香酸
メチル、ヒドロキシエチルセルロース、ピロリン酸カル
シウム、1.3−ブチレンゲリコール、ブドウ糖、プロ
パツール、プロピレングリコール、ベントナイト、ポリ
アクリル酸ナトリウム、ポリエチレングリコール30o
、ポリエチレングリコール400、ポリエチレングリコ
ール1500、ポリエチレングリコール6000、ポリ
オキシエチレン硬化ヒマシ油、ポリオキシエチレンステ
アリルエーテル、ポリオキシエチレンセチルエーテル、
ポリオキシエチレン(200)ポリオキシプロピレング
リコール(70)、ポリビニルピロリドン、ポリリン酸
ナトリウム、d−ボルネオール、マイクロクリスタリン
ワックス、マルチトール、ミツロウ、ミリスチン酸ジェ
タノールアミド、無水エタノール、無水クエン酸、無水
ケイ酸、無水ケイ酸アルミニウム、無水ピロリン酸ナト
リウム、メチルセルロース、■−メントール、dl−メ
ントール、モノオレイン酸ソルビタン、モノオレイン酸
ポリオキシエチレンソルビタン(20モル付加)、モノ
パルミチン酸ポリオキシエチレンソルビタン、(20モ
ル付加)、モノラウリル酸ソルビタン、モノラウリン酸
ポリオキシエチレンソルビタン(20モル付加)、ヤシ
油脂肪酸ジェタノールアミド、ユーカリ油、ラウリル硫
酸ナトリウム、ラウリル硫酸ジェタノールアミド、ラウ
ロイルサルコシンナトリウム、流動パラフィン、リン酸
−水素ナトリウム、リン酸二水素ナトリウム、リン酸三
ナトリウム、リン酸水素カルシウム、リン酸マグネシウ
ム、香料などが挙げられる。またトローチ、塗布剤、錠
剤、粉粒剤、含そう剤、口中清涼剤、チユーインガム、
ドリンク剤、キャンデー、エアゾール剤などにおいても
、製品の性状に応じた成分が適宜配合される。As other components of the present invention, appropriate components may be used depending on the type of oral composition. For example, in toothpaste, powdered toothpaste, water toothpaste, mouthwash, and other toothpastes, abrasives, binders, thickeners, foaming agents, fragrances, sweeteners, preservatives, etc. can be added.Ingredients include geraniol denatured alcohol, Heacetylated saccharide denatured alcohol, phenylethyl alcohol denatured alcohol, brucine denatured alcohol, linalool denatured alcohol, diethyl phthalate denatured alcohol, linaryl acetate denatured alcohol, benzyl acetate denatured alcohol, 10% denatonium benzoate alcohol solution denatured alcohol, Sodium N-acyl-L-glutamate, ascorbic acid, allantoin chlorhydroxyaluminum, sodium alginate,
Aloe extract, benzoic acid, sodium benzoate, titanium mica, ethanol, ethylenediaminetetrapolyoxyethylenepolyoxybrobylene, edetate disodium, edetate tetrasodium dihydrate, zinc chloride, sodium chloride, alkyldiaminoethylglycine hydrochloride, Chlorhexidine hydrochloride, pyridoxine hydrochloride, eugenol, scutellariae extract, γ-oryzanol, kaolin, brown algae extract, carrageenan, carboxyvinyl polymer, sodium carboxymethyl cellulose, hydrated amorphous silicon oxide, licorice extract, dried aluminum hydroxide gel, agar, dilute hydrochloric acid, xanthan gum , guaiazulene, citric acid, sodium citrate, glycerin, glycyrrhizic acid and its salts, chlorhexidine gluconate, gunjo, aluminum magnesium silicate, sodium silicate, light calcium carbonate, cinnamic alcohol, cinnamic aldehyde, crystalline cellulose, N- Hydrogenated beef tallow fatty acid acyl-L-sodium glutamate, synthetic sodium/magnesium silicate, wheat germ oil, saccharin, sodium saccharin, methyl salicylate, aluminum oxide, titanium oxide, Sikon extract, ground calcium carbonate, tartaric acid, distilled peppermint water, sucrose fatty acid Ester, new oil type glyceryl monostearate, aluminum hydroxide, sodium hydroxide, sodium N-stearoyl-L-glutamate, stevia extract, spearmint oil, purified water,
Sage extract, sodium cetyl sulfate, soap base,
Gelatin, sodium fibrin glycolate, sorbitol, potassium sorbate, talc, sodium bicarbonate,
Thymol, sodium dehydroacetate, sodium copper chlorophyllin, sodium lactate, lactose, glycerin, white sugar, peppermint oil, calcium hydrogen phosphate for toothpaste, isobutyl paraoxybenzoate, isopropyl paraoxybenzoate, ethyl paraoxybenzoate, butyl paraoxybenzoate, Propyl paraoxybenzoate, methyl paraoxybenzoate, hydroxyethyl cellulose, calcium pyrophosphate, 1,3-butylene gelicol, glucose, propatool, propylene glycol, bentonite, sodium polyacrylate, polyethylene glycol 30o
, polyethylene glycol 400, polyethylene glycol 1500, polyethylene glycol 6000, polyoxyethylene hydrogenated castor oil, polyoxyethylene stearyl ether, polyoxyethylene cetyl ether,
Polyoxyethylene (200) polyoxypropylene glycol (70), polyvinylpyrrolidone, sodium polyphosphate, d-borneol, microcrystalline wax, maltitol, beeswax, myristic acid jetanolamide, anhydrous ethanol, anhydrous citric acid, silicic anhydride , anhydrous aluminum silicate, anhydrous sodium pyrophosphate, methyl cellulose, ■-menthol, dl-menthol, sorbitan monooleate, polyoxyethylene sorbitan monooleate (20 mol addition), polyoxyethylene sorbitan monopalmitate, (20 mol) addition), sorbitan monolaurate, polyoxyethylene sorbitan monolaurate (20 mole addition), coconut oil fatty acid jetanolamide, eucalyptus oil, sodium lauryl sulfate, jetanolamide lauryl sulfate, sodium lauroyl sarcosinate, liquid paraffin, phosphoric acid Examples include sodium hydrogen phosphate, sodium dihydrogen phosphate, trisodium phosphate, calcium hydrogen phosphate, magnesium phosphate, and fragrance. In addition, troches, liniments, tablets, powders, mouthwashes, mouth fresheners, chewing gum,
Even in drinks, candies, aerosols, etc., ingredients are appropriately blended according to the properties of the product.
なお、本発明においては、上述した植物の溶媒抽出物に
加えて、デキストラナーゼ、溶菌酵素(塩化リゾチーム
等)、ムタナーゼ1、ソルビン酸、アレキシジン、ヒノ
キチオール、セチルピリジニウムクロライド、アルキル
グリシン、アルキルジアミノエチルグリシン塩、アラン
トイン、β−アミノカプロン酸、トラネキサム酸、アズ
レン、ビタミンE、モノフルオロリン酸ナトリウム、フ
ッ化ナトリウム、フッ化第1銅、水溶性第1もしくは第
2リン酸塩、第4級アンモニウム化合物などの有効成分
を配合することもできる。そして他の生薬抽出物として
、オウトウ、オウレン、リョウキュウ、エントウ、カシ
ュウ、クロモジ、ナンテンジツ、サンザシ、ボタンヒ、
コウジュ、オンジ、キヨウエン、トウニン、シソ、チョ
ウセンニンジン、ヨウバイヒ、ダイオウ、アカメガシワ
、ゲンノショウコ、ウィキョウ、キキョウ、ウワウルシ
、カシ、カンショ、チョウジ、アセンヤク、ショウバイ
等の抽出物も用い得る。In the present invention, in addition to the above-mentioned plant solvent extract, dextranase, lytic enzyme (lysozyme chloride, etc.), mutanase 1, sorbic acid, alexidine, hinokitiol, cetylpyridinium chloride, alkylglycine, alkyldiaminoethyl Glycine salt, allantoin, β-aminocaproic acid, tranexamic acid, azulene, vitamin E, sodium monofluorophosphate, sodium fluoride, cuprous fluoride, water-soluble mono- or di-phosphate, quaternary ammonium compound It is also possible to incorporate active ingredients such as. Other herbal medicine extracts include sagebrush, oren, ryokyu, perilla, kashu, kuromoji, nantenjitsu, hawthorn, botanhi,
Extracts of koju, chinensis, chinensis, chinensis, perilla, ginseng, Japanese rhubarb, rhubarb, red wattle, fenugreek, bellflower, fenugreek, oak, chinensis, clove, acacia japonica, sycamore, and the like may also be used.
〈作用〉
本発明に係る口腔用組成物は前記のシャクヤク、ビワヨ
ウ、ジヨウインチン、チユから選ばれる植物の溶媒抽出
物の1種または2種以上を含有することにより、ストレ
プトコッカスミュータンス由来のGTF阻害による爾垢
の形成を効果的に抑制し、従って主面の発生や歯周病疾
患を良好に防止する。<Function> The oral composition according to the present invention contains one or more solvent extracts of plants selected from the above-mentioned peony, chinensis, chinensis, and chinensis, thereby inhibiting GTF derived from Streptococcus mutans. It effectively suppresses the formation of plaque, thus effectively preventing the formation of major surfaces and periodontal disease.
〈実施例〉
以下に実施例を示し本発明の組成物を具体的に説明する
。しかし、本発明は実施例に限定されるものでない。<Example> The composition of the present invention will be specifically explained with reference to Examples below. However, the present invention is not limited to the examples.
実施例1
下記処方のものをそれぞれ混合し、本発明のチユ溶媒抽
出物を含有した線菌みがきを得た。Example 1 The following formulations were mixed to obtain a Streptomyces brush containing the Chuyu solvent extract of the present invention.
第2リン酸カルシウム・2水和物 50.0%グリ
セリン 18・0%カルボキシ
メチルセルロース 1.0%ソジウムラウリル
サルフエート 10%香料
1.0%サッカリン
01%チユ(50%エチルアルコール溶液抽出物)
3.0%フッ化ナトリ
ウム 0.1%精製水
遺100.0%
実施例2
下記処方のものをそれぞれ混合し、本発明のジヨウイン
チン溶媒抽出物を含有した水歯みがきを得た。Dibasic calcium phosphate dihydrate 50.0% glycerin 18.0% carboxymethylcellulose 1.0% sodium lauryl sulfate 10% fragrance
1.0% saccharin
01% Chuyu (50% ethyl alcohol solution extract)
3.0% sodium fluoride 0.1% purified water
Residue 100.0% Example 2 The following formulations were mixed to obtain a water toothpaste containing the chinensis solvent extract of the present invention.
エタノール 148 %グ
リセリン 100 %ポリオキ
シエチレン(60)硬化ヒマシ油 0.4 %リン
酸1水素ナトリウム 002%リン酸2
水素ナトリウム 001%サッカリンナ
トリウム 0.003%パラオキシ安
息香酸ブチル 0.007%ジヨウインチ
ン(エチルアルコール抽出)
1.0 %色素
0.2 %精製水
適100.0 %
実施例3
下記処方のものをそれぞれ混合し、本発明のシャクヤク
溶媒抽出物を含有した水歯みがきを得た。Ethanol 148% Glycerin 100% Polyoxyethylene (60) Hydrogenated Castor Oil 0.4% Sodium Monohydrogen Phosphate 002% Phosphoric Acid 2
Sodium hydrogen 001% Sodium saccharin 0.003% Butyl paraoxybenzoate 0.007% Diyouinthine (extracted with ethyl alcohol)
1.0% dye
0.2% purified water
100.0% Example 3 The following formulations were mixed to obtain a water toothpaste containing the peony solvent extract of the present invention.
エタノール 5.0%ソルビトー
ル70%水溶液 10.0%ラウリル硫酸ソーダ
1.0%サッカリンナトリウム 0
05%パラオキシ安息香酸ブチル 0.05%シャ
クヤク(水抽出)2.0%
香料 −0,2%
精製水 適
100.0%
実施例4
下記処方のものをそれぞれ混合し、本発明のジヨウイン
チン溶媒抽出物を含有したマウスウォッシュを得た。Ethanol 5.0% Sorbitol 70% aqueous solution 10.0% Sodium lauryl sulfate
1.0% saccharin sodium 0
05% Butyl paraoxybenzoate 0.05% Peony (water extraction) 2.0% Fragrance -0.2% Purified water Appropriate 100.0% Example 4 The following formulations were mixed, and the solvent extraction of the present invention was performed. A mouthwash containing the product was obtained.
エタノール 20.0 %グリセ
リン 15.0 %ポリオキシエチレ
ン・ポリオキシプロピレンポリマ−1,O%サッカリン
ナトリウム 0.02%パラオキシ安息香酸
ブチル 0.05%ジヨウインチン(エタノール
抽出液) 3.0 %色素
微量香料 0
. 2 %精製水 適1
00.0 %
実施例5
下記処方のものをそれぞれ混合し、本発明のシャクヤク
溶媒抽出物を含有したキャンデイ−を得た。Ethanol 20.0% Glycerin 15.0% Polyoxyethylene/polyoxypropylene polymer 1, O% Sodium saccharin 0.02% Butyl paraoxybenzoate 0.05% Diyointhine (ethanol extract) 3.0% Color
Trace fragrance 0
.. 2% purified water suitable 1
00.0% Example 5 The following formulations were mixed to obtain a candy containing the peony solvent extract of the present invention.
グラニユー糖 46.3 %水あめ
36.7 %クエン酸
1. 6 %シャクヤク(水抽出液)1.0
%
香料 0. 1 %水
適100.0 %
実施例6
下記処方のものをそれぞれ混合し、本発明のビワヨウ溶
媒抽出物を含有したキャンデイ−を得た。Granulated sugar 46.3% starch syrup
36.7% citric acid
1. 6% Peony (water extract) 1.0
% Fragrance 0. 1% water
Compatibility: 100.0% Example 6 The following formulations were mixed to obtain a candy containing the loquat extract of the present invention.
還元麦芽水あめ 90.0 %クエン酸
1.6 %ビワヨウ(水抽出液)1.
0 %
香料 0. 1 %水
連100.0 %
実施例7
下記処方のものをそれぞれ混合し、噴射剤と共にエアゾ
ール缶に充填し、本発明のショウインチン溶媒抽出物を
含有したマウススプレーを得た。Reduced malt starch syrup 90.0% citric acid
1.6% Biwayo (water extract) 1.
0% Fragrance 0. 1% water
Continuous 100.0% Example 7 The following formulations were mixed and filled into an aerosol can with a propellant to obtain a mouth spray containing the solvent extract of chinensis of the present invention.
エタノール(90プルーフ)
41.75%脱イオン水 41.75%
ソルビトール 10.00%グリセリン
3.00%POEソルビタンジイソ
ステアレート 1. 50
%ジヨウインチン(エタノール抽出1) 1.
00%ナトリウムサッカリン 0.50%実施
例8
下記処方のものをそれぞれ混合し、本発明のシャクヤク
溶媒抽出物を含有したデンタルクリームを得た。Ethanol (90 proof)
41.75% deionized water 41.75%
Sorbitol 10.00% Glycerin 3.00% POE Sorbitan Diisostearate 1. 50
% Diyointin (Ethanol extraction 1) 1.
00% Sodium Saccharin 0.50% Example 8 The following formulations were mixed to obtain a dental cream containing the peony solvent extract of the present invention.
ソルビトール 42.45%グリセリン
24.00%サイロプント704(シリカ
含有磨き剤) 22.0 0%脱イオ
ン水 3.00%ポリエチレングリコー
ル600 3,00%ソ
ルビタンジイソステアレート
1. 50%二酸化チタン 0.
50%安息香酸ナトリウム 0.50%カルボ
キシメチルセルロースナトリウム
0. 35%ナトリウムサッカリン 1.70
%シャクヤク(水抽出液) 1.00%〈発明
の効果〉
本発明に係る口腔用組成物は前記のシャクヤク、ビワヨ
ウ、ジヨウインチン、チユから選ばれる植物の溶媒抽出
物の1種または2種以上からなる酵素阻害剤を含有する
ことにより、ストレプトコッカスミュータンス由来のG
TF阻害による歯垢の形成を効果的に抑制し、従って虫
歯の発生や歯周病疾患を良好に防止する。Sorbitol 42.45% glycerin
24.00% Cyropunto 704 (silica-containing polish) 22.0 0% deionized water 3.00% polyethylene glycol 600 3,00% Sorbitan diisostearate
1. 50% titanium dioxide 0.
50% Sodium Benzoate 0.50% Sodium Carboxymethyl Cellulose
0. 35% sodium saccharin 1.70
% Peony (water extract) 1.00% <Effects of the Invention> The oral composition according to the present invention is made from one or more solvent extracts of plants selected from the above-mentioned Peony, Biwayou, Jyoinchin, and Chiyu. By containing an enzyme inhibitor, G. mutans derived from Streptococcus mutans
The formation of dental plaque by TF inhibition is effectively suppressed, and therefore the occurrence of dental caries and periodontal diseases are effectively prevented.
(以上) 特許出願人 アース製薬株式会社(that's all) Patent applicant: Earth Pharmaceutical Co., Ltd.
Claims (2)
ら選ばれる植物の溶媒抽出物の1種または2種以上を含
有することを特徴とする酵素阻害剤。(1) An enzyme inhibitor characterized by containing one or more solvent extracts of plants selected from peonies, peonies, peonies, and chiyus.
特徴とする口腔用組成物。(2) An oral composition characterized by containing the above-mentioned enzyme inhibitor as an active ingredient.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP2213138A JPH0495020A (en) | 1990-08-10 | 1990-08-10 | Enzyme inhibitor |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP2213138A JPH0495020A (en) | 1990-08-10 | 1990-08-10 | Enzyme inhibitor |
Publications (1)
Publication Number | Publication Date |
---|---|
JPH0495020A true JPH0495020A (en) | 1992-03-27 |
Family
ID=16634207
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
JP2213138A Pending JPH0495020A (en) | 1990-08-10 | 1990-08-10 | Enzyme inhibitor |
Country Status (1)
Country | Link |
---|---|
JP (1) | JPH0495020A (en) |
Cited By (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO1998042350A1 (en) * | 1997-03-21 | 1998-10-01 | Cheil Jedang Corporation | Cholesterol lowering pharmaceutical composition |
JPH11279039A (en) * | 1998-03-31 | 1999-10-12 | Saiseido Yakuhin Kk | Composition for oral cavity |
JP2002104983A (en) * | 2000-09-28 | 2002-04-10 | Kobayashi Pharmaceut Co Ltd | Anticariogenic agent |
WO2006106991A1 (en) * | 2005-03-31 | 2006-10-12 | Kobayashi Pharmaceutical Co., Ltd. | Composition for oral uses |
JP2010235566A (en) * | 2009-03-31 | 2010-10-21 | Kobayashi Pharmaceutical Co Ltd | Composition for oral cavity |
JP2019214538A (en) * | 2018-06-14 | 2019-12-19 | 小林製薬株式会社 | Agent for inhibiting entry of periodontal disease bacteria into gingival tissue cell |
-
1990
- 1990-08-10 JP JP2213138A patent/JPH0495020A/en active Pending
Cited By (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO1998042350A1 (en) * | 1997-03-21 | 1998-10-01 | Cheil Jedang Corporation | Cholesterol lowering pharmaceutical composition |
JPH11279039A (en) * | 1998-03-31 | 1999-10-12 | Saiseido Yakuhin Kk | Composition for oral cavity |
JP2002104983A (en) * | 2000-09-28 | 2002-04-10 | Kobayashi Pharmaceut Co Ltd | Anticariogenic agent |
WO2006106991A1 (en) * | 2005-03-31 | 2006-10-12 | Kobayashi Pharmaceutical Co., Ltd. | Composition for oral uses |
JP2010235566A (en) * | 2009-03-31 | 2010-10-21 | Kobayashi Pharmaceutical Co Ltd | Composition for oral cavity |
JP2019214538A (en) * | 2018-06-14 | 2019-12-19 | 小林製薬株式会社 | Agent for inhibiting entry of periodontal disease bacteria into gingival tissue cell |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
EP0324720B1 (en) | Saccharide inhibition of dental plaque | |
JPS647964B2 (en) | ||
KR930000059B1 (en) | Dental composition | |
JPH0424323B2 (en) | ||
JP2007131601A (en) | Composition for oral cavity | |
JPH0436228A (en) | Composition for oral cavity application | |
JPH0495020A (en) | Enzyme inhibitor | |
JPH0217525B2 (en) | ||
JP2001089385A (en) | Anti-dental caries agent | |
JPS6258328B2 (en) | ||
JPH11343247A (en) | Glucosyltransferase inhibitor | |
JPS6258329B2 (en) | ||
JP2736794B2 (en) | Plaque formation inhibitor | |
JP2001089345A (en) | Anti-dental caries agent | |
JP3319748B2 (en) | Caries inhibitor | |
JP4633399B2 (en) | Glucosyltransferase inhibitor | |
JP2001097835A (en) | Dental caries inhibitor | |
JP2001089386A (en) | Anti-dental caries agent | |
JP2859612B1 (en) | Caries prevention agent | |
JPS6258324B2 (en) | ||
JP3472172B2 (en) | Oral agent | |
JP2001089344A (en) | Anti-dental caries agent | |
JPH04159213A (en) | Composition for oral cavity | |
JP2002187843A (en) | Glucosyltransferase inhibitor | |
JP5892716B2 (en) | Oral composition |